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Summary 
 
Aprataxin protects nuclear and mitochondrial DNA against genotoxic stress, and 
loss-of-function mutations in the APTX gene cause the autosomal recessive 
cerebellar ataxia, Ataxia Oculomotor Apraxia 1 (AOA1) in humans. In an effort to 
extend current understanding of aprataxin function, this thesis examines the roles of 
aprataxin, especially in response to oxidative damage. Firstly, involvement of 
aprataxin during the gap-filling as well as the end-processing steps of single strand 
break repair were demonstrated using an in vitro single strand break repair assay 
using synthetic DNA substrates, cell-free lysates and/or recombinant proteins. Next, 
loss-of-function studies were conducted in Aptx
-/-
 mouse embryonic fibroblasts 
(MEFs) and tissues from adult mice harbouring a toxic gain-of-function mutant 
form of superoxide dismutase1 (SOD1
G93A
). Expression of the mutant SOD1
G93A 
enhanced sensitivity to oxidative damage in aprataxin-deleted cells and revealed an 
accelerated senescence and attenuated somatic growth phenotype. Together these 
findings suggest that aprataxin function is involved in optimal repair of single 
strand breaks and is therefore critical in maintaining cell function in situations of 
elevated oxidative stress.  
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1.1 DNA Damage and Repair 
 
DNA encodes the genetic instructions for the development and functioning of all known 
forms of life. Whilst this remarkable macromolecule is of fundamental importance in all 
living organisms, it is also extremely sensitive to damage.  Damaging agents from 
several sources cause a wide array of damages, or lesions, at an estimated rate of 1000 to 
1,000,000 molecular lesions per cell per day. Although this constitutes only 0.000165% 
of the human genome, unrepaired lesions can be highly problematic for the cell, by 
stalling transcription, and/or leading to genetic instability (mutation) and/or cell death 
(Figure 1.1) (Lindahl 1993a, Limoli et al. 1998). 
 
Sources of DNA damage may be either endogenous or exogenous. Endogenous sources 
include metabolic by-products such as reactive oxygen species (ROS), and errors made 
during replication. Exogenous sources include ionizing radiation (X-ray and γ rays), 
chemotherapeutic agents, and industrial chemicals such as polycyclic hydrocarbons, 
vinyl chloride and hydrogen peroxide, to name just a few. Further DNA damage is 
sustained independent of a distinct causative agent, because of the tendency of some 
chemical bonds in DNA to spontaneously hydrolyse, even under physiological 
conditions. Glycosidic bonds can hydrolyse, leading to abasic (AP) sites; and the 
spontaneous deamination of cytosine, adenine, guanine or 5-methylcytosine can result in 
uracil, hypoxanthine, xanthine and thymidine respectively (Figure 1.2) (Lindahl 1993). 
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Discontinuities in the sugar-phosphate backbone may be in one strand only, known as a 
single-strand break (SSB) or both strands, known as a double-strand break (DSB).  SSBs, 
although not considered to be genotoxic themselves, can be converted into DSBs by 
collision with a replication or transcription fork (Kuzminov 2001, Hoeijmakers 2001, 
Kouzminova and Kuzminov 2006). DSBs are considered to be the most genotoxic lesion 
that can arise and if left unrepaired or repaired inappropriately can lead to a variety of 
chromosomal aberrations and/or mis-segregation of chromosomes during mitosis 
(Hoeijmakers 2001). 
 
A complex network of biochemical systems has evolved in order to counter this threat 
by limiting the extent of damage sustained, detecting damage and mediating its repair. 
DNA damage response (DDR) impacts on a wide range of cellular events and is of 
particular interest to medical science as these processes are implicated in diverse human 
diseases. Despite the wide array of lesions and the plethora of components involved in 
their repair mechanisms, the DNA repair process in general remains a highly ordered, 
sequential one. First the lesions must be detected by sensor proteins, which recruit repair 
complexes. Various components of the repair complex are responsible for specific end 
processing, gap filling and ligation roles. Depending on the nature of the initial lesion, 
and to some extent the nature of the surrounding DNA (ie newly transcribed or not, 
hypermethylated or not), repair pathways can have elaborate and often overlapping roles. 
For example damage to transcribed regions of DNA are sensed and repaired 
preferentially in a process called transcription coupled repair (TCR).  
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The system demonstrates widespread redundancy: structurally and functionally distinct 
components compensate for one another under conditions where an activity is lost or 
suppressed, thus providing robustness against component or pathway failure. 
 
Over the last half century research into the DDR has revealed it to be a remarkably 
complex yet elegant system that coordinates countless proteins to detect and repair 
myriad lesions with remarkable speed and efficiency. This is necessarily done in concert 
with many other DNA-dependent processes such as DNA restructuring, transcription 
and replication. The focus of this thesis is aprataxin – the DNA repair protein product of 
APTX, the gene mutated in the neurodegenerative cerebellar ataxia, Ataxia Oculomotor 
Apraxia 1. First I will introduce the major forms of DNA repair, before discussing 
pathologies associated with defective DNA damage response. Finally I will discuss the 
current understanding of aprataxin, before presenting and discussing my findings. 
 
 
1.2 DNA Single-Strand Breaks 
 
SSBs are the most frequent type of DNA lesion, arising at a rate of approximately 
10,000 SSBs per cell per day (Lindahl and Nyberg 1972, Lindahl 1993a, Limoli et al. 
1998, Beckman and Ames 1997). Although SSBs are not considered to be very toxic 
themselves, if left unrepaired and allowed to convert into DSBs via collision with 
replication or transcription machinery, the volume of breaks would soon overwhelm the 
double strand break repair (DSBR) capacity of the cell (Kuzminov 2001, Deckbar et al. 
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2007). Consequently, cells have evolved rapid and efficient repair pathways collectively 
known as single-strand break repair (SSBR) (Reviewed in (Caldecott 2008)). 
 
The assembly of repair complexes and the progression of repair is dependent on the 
nature of the break - the size of the 'patch' required to fill the gap (a one-nucleotide patch 
is referred to as short-patch, multiple-nucleotide patches are referred to as long-patch) 
and the chemical nature of the break termini. Structures of the most common 3' and 5' 
break termini are shown in Figure 1.3 and Figure 1.4, respectively.  
 
SSBs may result directly from damage or they may result indirectly, from excision of 
damaged or mismatched bases. Indirect SSBs may arise following the excision step of 
base excision repair (BER), nucleotide excision repair (NER) or mismatch repair 
(MMR). The processes by which these breaks are repaired are similar in some respects 
and distinct in others (Figure 1.5).  
 
Endogenous SSBs can also arise via the abortive action of the enzyme topoisomerase I 
(Top1). Top1 relaxes supercoiled duplex DNA during transcription and DNA replication 
by nicking one strand of the DNA double helix, thereby allowing it to unwind (Roca 
1995, Wang 2002). A transient cleavage complex is formed, in which Top1 becomes 
covalently linked via a 3' phosphotyrosyl bond to the DNA, before the nick is resealed. 
These nicks are usually resealed rapidly. However if a DNA or RNA polymerase 
collides with Top1 before the nick is resealed, then the cleavage complex can become 
trapped as a Top1-associated single strand break (Top1-SSB), and the SSB cannot be 
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religated as usual (Pommier et al. 2003). Top1-SSBs can also become trapped if the 
cleavage complex occurs in close proximity to another DNA lesion (Pourquier et al. 
1997). In this case the Top1 peptide bound to the 3' terminus of the break must be 
degraded and the tyrosine residue removed. A phosphodiesterase called Tyrosyl-DNA 
phophodisterase 1 (TDP1) is stabilised at the SSB site via interaction with LigIIIα and 
performs this end processing function (Figure 1.6) (Chiang, Carroll, and El-Khamisy 
2010). Mutation of the TDP1 gene leads to the autosomal recessive cerebellar ataxia, 
spinocerebellar ataxia with axonal neuropathy 1 (SCAN1) (El-Khamisy et al. 2005). 
This disease shares some common features with AOA1 and is discussed in section 1.5.2. 
 
The Top1 inhibitor camptothecin (CPT) increases the half-life of Top1 cleavage 
complexes and is used experimentally to increase the level of Top1-SSBs (Pourquier et 
al. 1997)). CPT treatment and TDP1 deletion have been used experimentally to stabilize 
single strand breaks in order to examine processes of repair (El-Khamisy et al. 2009).  
 
1.2.1  DNA Single-Strand Break Repair 
 
The various overlapping repair pathways dedicated to repairing SSBs are collectively 
known as single-strand break repair (SSBR) and proceed through three key stages of 
repair; detection of the break, processing of damaged termini (and gap filling if 
necessary), and DNA ligation (Figure 1.5). Again, the repair process selected depends 
upon nature of the break. The SSB may arise directly due to the action of a damaging 
agent, in which case it is referred to as a „direct‟ SSB, or they may be as a result of the 
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excision of nucleotides as part of the Nucleotide Excision Repair (NER), Mismatch 
Repair (MMR) and Base Excision Repair (BER) pathways in which case it is referred to 
as an „indirect‟ SSB and is repaired differently (i.e. Figure 1.5).  
 
The distinction between these pathways is beginning to fade as evidence grows of multi-
functional repair proteins, active across what were previously thought to be distinct 
pathways, and the condition-specificity of pathway election. These findings challenge 
the notion that specific lesions are repaired by specifically dedicated repair pathways. 
The redundancy and versatility of the system confound its categorization. Hence, it is 
perhaps more useful to discuss SSBR in terms of functionalities and mechanisms rather 
than ill-defined pathways. First, I will introduce the precursor processes of indirect 
SSBR - BER, NER, and MMR. Then I will discuss each of the steps of SSB repair in a 
little more detail. 
 
1.2.2  Base Excision Repair 
 
BER resolves DNA base damage, including oxidation and alkylation. It also repairs 
abasic sites, which may arise directly due to the action of a damaging agent - as 
accounts for an estimated 20% of all damage induced by ionizing radiation (Von 
Sonntag 1987, Demple and DeMott 2002) or due to the hydrolysis of bases in aqueous 
solution. It is estimated that 2000-10000 depurination events occur per cell per day 
(Lindahl and Nyberg 1972, Lindahl 1993a). 
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One noteworthy example of base damage is the spontaneous deamination of cytosine to 
uracil, which can result in the mis-incorporation of adenine and a CG→TA point 
mutation. Spontaneous cytosine deamination events are estimated to occur 60-500 times 
per cell per day (Krokan, Drabløs, and Slupphaug 2002, Barnes and Lindahl 2004). 
Cytosine deamination can also be caused by ROS-induced oxidative damage resulting 
from ionising radiation (Bjelland 2003). The most common reason for base loss is 
oxidation following nucleophilic attack by ROS (Ward et al. 1987, Limoli et al. 1998) - 
for example the formation of 8-oxo-G and thymine glycol from guanine and thymine, 
respectively (Figure 1.7).  The oxidised form of guanine, 8-hydroxyguanine, is a 
commonly occurring oxidative lesion and is the most frequently used marker for 
oxidative base damage (Kasai, Tanooka, and Nishimura 1984; Lindahl 1993). This 
oxidative lesion is particularly mutagenic as adenine can be inserted opposite an 8-oxo-
G lesion with the same efficiency as cytosine during DNA replication, resulting in a GC 
→ TA point mutation (Figure 1.8) (Shibutani, Takeshita, and Grollman 1991). The 
continuous generation of ROS during normal cellular metabolism mean that offsetting 
this threat is of major importance to preserving genomic integrity and cell survival 
(Beckman and Ames 1997, Cadet 2003, Sander et al. 2005). A detailed discussion of 
oxidative damage and mechanisms for its prevention and repair is provided in section 
1.4.3. 
 
During BER, detection of base damage is achieved in a different manner to that of direct 
SSBs. Altered bases cause minor perturbations in the DNA helix, which are recognised 
and cleaved by specific DNA glycosylases. PARP1 accumulates at sites of base damage 
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although there is some question over whether its recruitment role here at indirect SSBs 
is as important as at direct SSBs (Durkacz et al. 1980, El-Khamisy et al. 2003, 
Campalans et al. 2013, Campalans et al. 2005). Independent of PARP1, XRCC1 (X-ray 
cross complementing 1) can interact with the DNA glycosylases: oxoguanine 
glycosylase (OGG1), nei endonuclease VIII-like 1 (NEIL1), nei endonuclease VIII-like 
2 (NEIL2), methylpurine-DNA glycosylase (MPG) and apurinic/apyrimidinic 
endonuclease 1 (APE1) (Vidal et al. 2001, Marsin et al. 2003, Das et al. 2006, 
Campalans et al. 2005) enabling subsequent co-ordination of the repair complex and 
execution of the next necessary repair step. See Figure 1.5 for a graphic outline of the 
processes and components involved in the repair of a SSB arising as a BER-intermediate. 
A detailed account of each process is provided in section 1.2.5-1.2.8. 
 
1.2.3  Nucleotide Excision Repair 
 
Nucleotide excision repair (NER) is a highly versatile DNA repair pathway that resolves 
a wide array of DNA lesions, including bulky DNA adducts that distort the DNA double 
helix (Nouspikel 2009). UV radiation, especially UVB which is a component of sunlight, 
can cause such bulky, helix distorting adducts referred to as photodamage (Jean Cadet, 
Sage, and Douki 2005). Cyclobutane pyrimidine dimers (CPD) and (6-4) pyrimidone 
photoproducts ((6-4)PPs) are the most commonly occurring type of lesion sustained 
(Jean Cadet, Sage, and Douki 2005). Other bulky DNA adducts that are repaired by 
NER include those induced by polycyclic aromatic hydrocarbons, commonly found in 
air, food, drinking water and tobacco smoke (Peltonen and Dipple 1995). 
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NER is highly versatile by virtue of excising a short patch of DNA surrounding the 
lesion, bypassing the need for particular DNA repair enzymes specific to the type of 
damage. There are two pathways that operate within NER; global genome NER (GGR), 
which recognises and repairs DNA adducts that cause major distortions of the double 
helix anywhere in the genome, and transcription coupled repair (TCR), which repairs 
transcription-blocking lesions and is associated with the transcription machinery (Figure 
1.9) (Gillet and Schärer 2006, Tornaletti 2009, Nouspikel 2009, Cloney 2011). 
 
Two major damage detection complexes are involved in GGR. The XPC complex is 
involved in the recognition of major helix distorting lesions, such as (6-4)PPs 
(Kusumoto et al. 2001, Sugasawa et al. 2001, Araki et al. 2001), but is unable to 
recognise lesions which cause minor distortions in the double helix, such as CPDs. 
Recognition of these minor helix distorting lesions is performed by the XPE/XPC 
complex (Kim, Patel, and Choi 1995, Payne and Chu 1994). In TCR, the lesion is 
encountered by an elongating RNA polymerase, causing stalling of the transcription 
bubble (Payne and Chu 1994). Cockayne syndrome A and cockayne syndrome B 
proteins (CSA and CSB) are recruited to the stalled transcription complex and are 
required for efficient TCR (Tu, Bates, and Pfeifer 1997, Van Gool et al. 1997). 
Following distinct mechanisms for detection of the lesion, the GGR and TCR pathways 
converge (Nouspikel 2009). 
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The next step of NER is the unwinding of the DNA helix to form a 'bubble' around the 
lesion. This is carried out by the transcription factor TFIIH, a large complex consisting 
of 10 subunits, including the two ATP-dependent DNA helicases XPB and XPD, which 
have complementary 3' - 5' and 5' - 3' helicase activities respectively (Tapias et al. 2004, 
Wang et al. 1996). At this point the proteins XPA, XPG and the ssDNA binding protein 
RPA are recruited via interactions with TFIIH (Tapias et al. 2004, Volker et al. 2001). 
The coating of RPA on the undamaged DNA strand is essential for the incision and 
DNA synthesis steps (Coverley 1992). XPA is essential for NER to proceed although its 
precise role at this early step has not yet been determined (Tanaka et al. 1990, Gillet and 
Schärer 2006). One potential role it could perform is strand discrimination to ensure that 
RPA coats only the undamaged DNA strand, allowing proper assembly of the pre-
incision complex (Sugasawa et al. 2001). Finally, ERCC1-XPF is recruited to the pre-
incision complex via interaction with XPA (Park and Sancar 1994, Nagai et al. 1995). 
 
Following formation of the denaturation 'bubble' and assembly of the pre-incision 
complex, dual incisions are made at the 3' and 5' ends of the 'bubble', at the ssDNA-
dsDNA junctions, by the structure-specific endonucleases XPG and ERCC1-XPF 
respectively (Park et al. 1995, O‟Donovan et al. 1994, Matsunaga et al. 1995). 
Following excision, the gap is filled by the replicative polymerases Pol-δ and Pol-ε in 
association with PCNA, and the remaining nick is ligated by LigIII, which is stabilized 
at the break by forming a complex with XRCC1 (Popanda and Thielmann 1992, Shivji, 
Kenny, and Wood 1992, Moser et al. 2007).  
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1.2.4  Mismatch Repair 
 
Classical Watson-Crick base pairing - in which cytosine (C) forms hydrogen bonds with 
guanine (G), and thymine (T) forms hydrogen bonds with adenine (A) - is a key feature 
of double stranded DNA and allows for the error-free replication and maintenance of 
genetic information (Watson and Crick 1953). 
 
However, occasionally during replication mismatches can occur in which non-Watson-
Crick combinations of bases form bonds. The bases may both be undamaged, or an 
undamaged base may pair with uracil or an undamaged base may bond with a damaged 
base, such as 8-oxo-G with A (Fig 1.8) (Shibutani, Takeshita, and Grollman 1991).  
 
DNA mismatches arising from base damage are generally recognised and repaired by 
specific DNA glycosylases during BER, while other DNA mismatches are generally 
recognised and repaired by a highly conserved repair pathway known as DNA mismatch 
repair (MMR), reviewed in (Kunkel and Erie 2005). In both cases, strand discrimination 
(identification of the nascent strand from the parental strand) is crucial to maintain 
genomic stability. In gram-negative bacteria transient hemimethylation is exploited to 
distinguish the strands - in the minutes following replication the parental (template) 
strand is methylated and the daughter strand is not (Hare and Taylor 1985). In other 
prokaryotes and eukaryotes the exact mechanism of strand discrimination is not clear 
but evidence suggests that the nicks present on the newly synthesized strand are sites for 
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replication factor C (RFC)-dependent loading of the DNA sliding clamp protein PCNA, 
in an orientation-specific manner, thereby identifying the nascent strand and recruiting 
repair proteins accordingly (Pluciennik et al. 2010), and that SUMOylation of PCNA 
acts to stabilise the replication fork (Gali et al. 2012).  
 
In humans, MMR is initiated after replication by the recognition of mismatches by two 
heterodimers, MSH2-MSH6 and MSH2-MSH3 (Kunkel and Erie 2005). Next, 
MLH1/PMS2 is recruited to form a ternary complex, which is necessary for the 
completion of MMR in human cells (Kunkel and Erie 2005). PCNA appears to play a 
role in the recruitment of MMR proteins in the vicinity of a replication fork via 
interaction with MSH6 and MSH3 (Clark et al. 2000). Once the MMR machinery has 
been assembled at the site of damage, a nick is introduced 5' to the mismatch by PMS2 
in a reaction that is dependent on PCNA. The 5' -> 3' exonuclease EXO1 then degrades 
the nicked strand (Genschel, Bazemore, and Modrich 2002). The single strand gap is 
then rapidly bound by RPA, which facilitates Pol-δ or Pol-η dependent DNA synthesis.  
Finally the nick is ligated by DNA ligase I (Kunkel and Erie 2005). Non-canonical 
variations on replication-coupled MMR are discussed in (Kunkel and Erie 2005) but will 
not be described here. 
 
The foremost consequence of defective MMR is an increased abundance of point 
mutations across the genome. In prokaryotes this elevated mutation rate acts to improve 
the survival fitness of colonies under stress. In humans the improved survival fitness of 
sub-populations of cells can result in cancer (Kunkel and Erie 2005). 
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1.2.5  Single-Strand Break Detection and Signalling 
 
Detection of direct SSBs is carried out by the enzyme poly (ADP-ribose) polymerase 1 
(PARP1) (D‟Amours et al. 1999, Kim, Zhang, and Kraus 2005) (Figure 1.5). Of the 
seventeen PARP proteins identified by homology searching of the human genome 
database, three (PARP1, PARP2, and PARP3) have characterized roles in DNA repair. 
PARP1, the most abundant of the PARP proteins, is a multi-functional DNA repair 
protein that binds DNA breaks with high affinity. Once bound, it catalyses the 
polymerisation of long branched poly(ADP-ribose) chains, predominantly upon itself, 
but also onto other target molecules . These include histones, DNA topoisomerases I and 
II, and DNA helicases (Benjamin and Gillg 1980, Bramson et al. 1993). Accumulation 
of PAR at DNA breaks leads to an accumulation of negative charge and the recruitment 
of XRCC1 (Caldecott et al. 1996, El-Khamisy et al. 2003, Masson et al. 1998), a 
scaffold protein which serves as an assembly platform for repair complexes comprising 
of several repair proteins, including PNK, DNA ligase III-α, DNA polymerase-β, APE1 
and aprataxin (Marintchev et al. 2000, Loizou et al. 2004, Luo et al. 2004, Vidal et al. 
2001) DNA ligase III-α and DNA polymerase-β appear to be present in all XRCC1 
complexes, other factors are variable. Once maximally autoribosylated, the PARP1 
molecule disassociates from the break (Ferro, Higgins, and Olivera 1983, Zahradka and 
Ebisuzaki 2005) and is rapidly targeted by the enzyme poly(ADP-ribose) 
glycohydrolase (PARG) which catalyses the degradation of the poly(ADP-ribose) 
polymers, allowing PARP1 to be recycled (Figure 1.5) (Cortes et al. 2004, Fisher et al. 
2007). 
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PARP1 depletion, deletion or inhibition results in decreased rates of SSBR (Fisher et al. 
2007, Le Page et al. 2003, Godon et al. 2008), as does depletion of PARG. XRCC1-
dependent recruitment of repair factor complexes to SSBs facilitates rapid repair, both 
by concentrating repair proteins at the site of damage, and stimulating their activity and 
is essential for efficient repair (Vidal et al. 2001, Whitehouse et al. 2001). Xrcc1
-/-
 mice 
do not survive past embryonic day 6.5 ( Tebbs et al. 1999; Tebbs, Thompson, and 
Cleaver 2003). Furthermore, four Chinese hamster ovary (CHO) cell lines that harbour 
mutations in XRCC1 display global SSBR defects and hypersensitivity to DNA 
damaging agents (Caldecott 2003). 
 
During BER, detection of base damage is achieved in a different manner to that of direct 
SSBs. Altered bases cause minor perturbations in the DNA helix which are recognised 
and cleaved by specific DNA glycosylases. PARP1 accumulates at sites of base damage 
although there is some question over whether its recruitment role here at indirect SSBs 
is as important as at direct SSBs (Durkacz et al. 1980, Campalans et al. 2013). 
Independent of PARP1, XRCC1 can interact with the DNA glycosylases OGG1, NEIL1, 
NEIL2 and MPG and APE1 (Vidal et al. 2001, Marsin et al. 2003, Campalans et al. 
2005, Das et al. 2006) enabling subsequent co-ordination of the repair complex and 
execution of the next necessary repair step. 
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1.2.6  Single-Strand Break End Processing 
 
As previously mentioned, the majority of SSBs have 'damaged' termini. For successful 
gap filling and DNA ligation to take place the conventional 3'OH and 5'-P chemistries 
have to be resolved. Consequently a wide array of DNA end-processing factors have 
evolved to repair the various different moieties present at damaged termini (see Figures 
1.3 and 1.4 for the structure of various different moieties present at damaged termini.) 
The importance of DNA end-processing is highlighted by the elucidation of three human 
neurological disorders, found to be associated with mutations in SSBR proteins and 
defective end-processing since the turn of the millennium. These serious genetic 
disorders are; ataxia oculomotor apraxia 1 (AOA1), X-linked mental retardation 
(XLMR), spinocerebellar ataxia with axonal neuropathy 1 (SCAN1) and microcephaly 
early-onset intractable seizures and developmental delay (MCSZ), in which aprataxin, 
Cul4 E3 ubiquitin ligase, TDP1 and PNK are mutated respectively (Kerzendorfer et al. 
2010, Date et al. 2001, Moreira et al. 2001, Takashima et al. 2002, Shen et al. 2010). 
 
APE1 is an important SSBR factor involved in the repair of both direct and indirect 
SSBs. In addition to its AP lyase activity it can also process damaged 3' termini - 3'-
phosphoglycolate (3‟PG) with high affinity and 3'-hydroxyl (3‟OH) (Figure 1.3) with 
low affinity (Chen, Herman, and Demple 1991, Demple and Harrison 1994; Izumi et al. 
2000). APE1 is essential in mammalian cells and Ape1
-/-
 mice do not survive past 
embryonic day 4-5 (Xanthoudakis et al. 1996, Tadahide Izumi et al. 2005). 
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Aprataxin is a member of the Hint-like histidine triad (HIT) superfamily (Clements et al. 
2004, Brenner 2002, Kijas et al. 2006) (Figure 1.10). The forkhead associated domain at 
the N-terminus of aprataxin is homologous to that of PNK and mediates interactions 
with CK2-phosphorylated XRCC1 and XRCC4 (Figure 1.11) (Sano et al. 2004, 
Clements et al. 2004, Luo et al. 2004, Date et al. 2004, Gueven et al. 2004). Aprataxin 
and PNK have been confirmed to bind to the same CK2-phosphorylated cluster on 
XRCC1, and are present in two mutually exclusive complexes (Luo et al. 2004). 
Aprataxin has also been reported to co-immunoprecipitate with PCNA (Hirano et al. 
2007), PARP1 and p53 (Gueven et al. 2004). During normal ligation 5‟ adenosine 
monophosphate (5‟AMP) is a transient intermediary (Figure 1.12). In a process called 
abortive ligation, 5‟AMP can persist at unligated SSBs (Figure 1.13). This process is 
described in detail in section 1.2.8. Aprataxin catalyses the hydrolysis of 5'-AMP (the 
product of abortive ligations) to release AMP and restore the correct 5' terminus for 
ligation, a 5'P (Figure 1.14). It has also been reported that aprataxin can remove 3'P and 
3'PG with very low efficiency (unlikely to compete with APE1 or PNK in vivo) 
(Takahashi et al. 2007). Mutations in aprataxin result in the neurodegenerative disorder 
AOA1 in humans, but deletion produces no phenotype in mice, suggesting that its 
functions are only crucial in maintaining the long-term health of the nervous system in 
long-lived mammals. 
 
Tdp1 resolves DNA-peptide adducts which occur as a result of abortive topoisomerase I 
reactions (El-Khamisy et al. 2005) (Figure 1.6). SCAN1 is a late onset autosomal 
recessive ataxia  caused by mutations in the TDP1 gene. SCAN1 patient cells display 
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elevated levels of DNA-peptide adducts and hypersensitivity to camptothecin, a 
chemotherapeutic drug that causes abortive topoisomerase I reactions (Miao et al. 2006). 
Camptothecin and Tdp1-deletion have both been used as strategies to study SSBs 
experimentally (El-Khamisy et al. 2009).  
 
PNK is a bi-functional protein that possesses both 3' phosphatase and 5' kinase activity 
(Jilani et al. 1999, Karimi-Busheri et al. 1998, Whitehouse et al. 2001, Bernstein et al. 
2005). PNK has an N-terminal FHA domain, via which it interacts with CK2-
phosphorylated XRCC1 and XRCC4, and phosphatase and kinase catalytic domains 
(Loizou et al. 2004, Whitehouse et al. 2001, Bernstein et al. 2005). PNK is considered to 
be a critical protein in SSBR due to the large proportion of 3'-P termini at SSBs. This is 
the predominant terminus produced following excision and cleavage of base damage by 
a bi-functional DNA glycosylase in a β-δ-elimination reaction and following TDP1 
activity during the repair of TOP1-SSBs (Figure 1.6) (Caldecott 2001, Limoli et al. 1998, 
O‟Connor and Laval 1989, Interthal, Pouliot, and Champoux 2001).   Although other 
proteins (e.g. APE1) possess 3' phosphatse activity, PNK function is necessary for 
efficient repair in humans.  Mutations in PNK result in the human developmental 
disorder known as „microcephaly, early-onset, intractable seizures and developmental 
delay‟ (MCSZ) (Shen et al. 2010). As a secondary role, PNK can also phosphorylate 
5' OH termini, which may arise as the result of ROS-induced sugar disintegration or as a 
product of TDP1 activity (Ward et al. 1987, Caldecott 2001, Interthal, Pouliot, and 
Champoux 2001). 
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1.2.7  Single-Strand Break Gap Filling 
 
Since most SSBs have at least one missing base, a gap-filling step usually follows end-
processing. Depending on the extent of the gap, one of two sub-pathways will be taken. 
Short-patch repair is the term applied to the process in which a one-nucleotide gap is 
filled with a single nucleotide (Dianov, Price, and Lindahl 1992) and long-patch repair 
refers to the process whereby a patch of 2 or more nucleotides is synthesized, displacing 
a 5' single-stranded flap which is then cleaved by flap endonuclease 1 (FEN1) (Figure 
1.15) (Frosina et al. 1996, Klungland and Lindahl 1997, Kim, Biade, and Matsumoto 
1998, Mosbaugh and Linn 1984, Singhal, Prasad, and Wilson 1995). These processes 
described are reviewed in (Caldecott 2001). 
 
Numerous reports of defective short-patch repair using cell-free extracts from Pol-β-/- 
MEFs strongly suggest an important role for Pol-β in short-patch repair (Singhal, Prasad, 
and Wilson 1995, Sobol et al. 1996, Kubota et al. 1996, Klungland and Lindahl 1997, 
Karimi-Busheri et al. 1998, Fortini et al. 1998, Winters et al. 1999, Dianov et al. 1999, 
Whitehouse et al. 2001, Podlutsky et al. 2001, Pascucci et al. 2002, Dianova et al. 2004, 
Vens, Hofland, and Begg 2007). While these reports demonstrate Pol-β to be the most 
efficient gap-filling agent at single-nucleotide gaps, it is most certainly not the only one. 
Quiescent Pol-β -/- MEFs are sensitive to γ-irradiation, while their cycling counterparts 
are not (Niedernhofer et al. 2006, Vermeulen et al. 2007, Vermeulen et al. 2008) 
suggesting that replication-coupled pathways can adequately compensate for loss of Pol-
β function. Another member of the X-family of polymerases, Pol-λ, has 5-dRP lyase 
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activity and can also carry out single nucleotide incorporation during short-patch repair 
in the absence of Pol-β, as can Pol-ι - a member of the Y-family of polymerases 
(Bebenek et al. 2001, Rajendra Prasad et al. 2003, Vens, Hofland, and Begg 2007). The 
Y-family polymerases are low-fidelity polymerases, which are involved in the bypass of 
DNA lesions during translesion synthesis (Reviewed in (Prakash, Johnson, and Prakash 
2005)), the importance of which is highlighted by the hypersensitivity of Pol-ι -/- 
fibroblasts to hydrogen peroxide (Petta et al. 2008).  
 
The whole system exhibits extensive redundancy - where one function is missing or 
depleted, there are generally several others capable of compensating. This is especially 
true of gap-filling as a wide array of proteins possess overlapping DNA polymerase 
activity. Several polymerases have been implicated in long-patch repair. Some reports 
suggest that Pol-β carries out strand displacement synthesis during long-patch repair in a 
reaction that is stimulated by the presence of PARP1 and FEN1 (Dianov et al. 1999, 
Prasad et al. 2001, Prasad et al. 2000, Liu et al. 2005, Balakrishnan et al. 2009), while 
some reports suggest that Pol-β is only responsible for the initiation of synthesis and 
other polymerases carry out the strand displacement reaction (Parlanti et al. 2004, 
Podlutsky et al. 2001, Dianov et al. 2001, Dianov et al. 1999). In vitro repair 
experiments using extracts from Pol-β-/- MEFs show that the replicative polymerases 
Pol-δ and Pol-ε can also carry out strand displacement synthesis in a reaction that is 
dependent on the presence of proliferating cell nuclear antigen (PCNA) (Dresler and 
Lieberman 1983a, Dresler and Lieberman 1983b, DiGiuseppe and Dresler 1989, Frosina 
et al. 1996, Klungland and Lindahl 1997, Stucki et al. 1998, Fortini et al. 1998, Parlanti 
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et al. 2004). 
 
1.2.8  Single-Strand Break Ligation 
 
Once the gap has been filled, the final stage of SSBR is DNA ligation, whereby the 
sugar-phosphate backbone of DNA is resealed. This process is carried out in 
mammalian cells by two DNA ligases; DNA Ligase III-α (LigIIIa) and DNA Ligase I 
(LigI) (Reviewed in (Ellenberger and Tomkinson 2008). The ligase most associated with 
short-patch repair is LigIIIα (Brookman, Tebbs, and Allen 1994, Caldecott et al. 1994, 
Cappelli et al. 1997, Sleeth, Robson, and Dianov 2004). LigIIIα  is one of three 
polypeptides generated by the LIG3 gene; the nuclear version that interacts with XRCC1 
(LigIIIα), a mitochondrial version (mtLigIIIα), which differs to the nuclear version only 
by the presence of an N-terminal mitochondrial localisation signal (MLS), and a germ-
line specific isoform called LigIIIβ, which is generated by an alternative splicing event 
and lacks the C-terminal BRCT domain (Lakshmipathy and Campbell 1999, Perez-
Jannotti, Klein, and Bogenhagen 2001, Mackey et al. 1997). 
 
LigIIIα binds XRCC1 via a constitutive interaction between each of their BRCT 
domains that is required for stability of the ligase in vivo (Caldecott et al. 1994, 
Caldecott et al. 1995, Nash et al. 1997, Taylor et al. 1998, Dulic et al. 2001). LigIIIα can 
also ligate DSBs, an activity which requires both the N-terminal ZnF and the catalytic 
core (Cotner-Gohara et al. 2008). 
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LigI is the ligase most associated with long-patch repair (Karimi-Busheri et al. 1998, 
Matsumoto et al. 1999, Pascucci et al. 1999, Prasad et al. 1996, Winters et al. 1999, 
Sleeth, Robson, and Dianov 2004). Its role here is dependent on its interaction with 
PCNA (Levin et al. 1997, Levin et al. 2000). Aside from its role in SSBR, LigI also 
plays an essential part in the maturation of Okazaki fragments during DNA replication 
(Waga and Stillman 1998).  
 
The roles of LigI and LigIIIα have mostly been elucidated as a result of in vitro repair 
assays and two recent studies in vivo suggest there may be greater cross-over between 
ligase functionalities than previously appreciated (Simsek et al. 2011, Katyal and 
McKinnon 2011, Gao et al. 2011). DNA ligases are nucleotidyltransferases (NTases) 
that exploit a high energy cofactor (ATP) to catalyse phosphodiester bond formation in a 
universal three-step reaction mechanism (Figure 1.12).  
 
In the first step of DNA ligation, the ligase reacts with ATP to produce a ligase-
adenylate intermediate in which AMP is covalently linked to the active site lysine via a 
phosphoamide bond, and a pyrophosphate molecule is released (Olivera et al. 1968, 
Harvey et al. 1971, Weiss, Thompson, and Richardson 1968, Bernard Weiss and 
Jacquemin-Sablon 1968, Gumport and Lehman 1971, Lehmann 1978). This reaction is 
very energetically favourable and therefore very rapid. During this step an oxygen of the 
5'P group attacks the phosphorus of the AMP group, dispelling the lysine and 
transferring the adenylate group onto the 5'P, forming a 5'-AMP DNA intermediate 
(Odell et al. 2000, Nair et al. 2007). This is accompanied by a conformational change in 
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the ligase and a possible reconfiguration of metal ions in the active site (Odell et al. 
2000, Nair et al. 2007). 
 
The final step of ligation is the resealing of the phosphodiester backbone (Lehmann, 
1978). During this step the non-adenylated ligase catalyses the nucleophilic attack of the 
5'AMP by the 3'OH, thereby displacing the AMP and joining the two polynucleotides by 
formation of a phosphodiester bond (Odell et al. 2000; Crut et al. 2008; Nair et al. 2007). 
This step is very rapid - the rate of phosphodiester bond formation is much faster than 
the adenylation of the DNA (Crut et al. 2008). 
 
Under certain circumstances, such as a premature attempt to ligate a SSB with a 
damaged 3' terminus, the ligation reaction will stall and a stable abortive ligation 
intermediate (5'-AMP) will persist (Figure 1.13). Aprataxin can cleave 5‟-AMP to 
restore the ligatable 5‟-P terminus (Ahel et al. 2006). The discovery of the 
neurodegenerative disorder AOA1, a disease caused by mutations in APTX and 
resulting loss of function in the gene product aprataxin - the protein that cleaves 5'-AMP 
- suggests that the persistence of abortive ligation intermediates is toxic (Date et al. 2001, 
Barbot et al. 2001). 
 
1.2.9  Replication-Coupled Single-Strand Break Repair 
 
The SSBR pathways described previously are very rapid and seem to operate throughout 
the cell cycle and are therefore known as 'global' SSBR (Reviewed in (Caldecott 2008)). 
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However there is some evidence that alternative SSBR pathways operate at different 
times throughout the cell cycle, specifically during S-phase. It has been shown that 
XRCC1 co-localises with PCNA at replication foci (Fan et al. 2004) and a complex 
consisting of APE1, uracil N-glycosylase 2 (UNG2), XRCC1 and Pol-β, replicative 
polymerases Pol-α, Pol-δ/ε and DNA ligase I co-associates with DNA replication 
proteins in human cycling cells (Parlanti et al. 2007, Otterlei et al. 1999). It has also 
been shown that the BRCT domains within XRCC1 have a role in the repair of SSBs 
during S-phase (Taylor et al. 2000). It may be that a core SSBR complex associates with 
the replication fork during S-phase and repairs SSBs that hit the replication fork. This 
hypothetical pathway has been termed replication-coupled SSBR (RC-SSBR) (Caldecott 
2008, Caldecott 2001, Caldecott 2003). It is considered likely that this hypothetical 
pathway would resemble long-patch repair due to the fact that many of the proteins 
involved in long-patch repair, such as Pol-δ/ε, PCNA, FEN1 and LigI, are also present 
in the replication machinery (Fan et al. 2004, Parlanti et al. 2007, Otterlei et al. 1999) 
but may differ in detection mechanisms. 
 
Confirmation of the existence of this pathway would help to explain the lack of cancer 
predisposition in SSBR-defective disorders, as unrepaired SSBs repaired by a RC-SSBR 
before the encountering the replication fork would avoid conversion into a double strand 
break. It has also been suggested that this pathway could operate in conjunction with the 
DSBR pathway homologous recombination (HR), due to the fact that SSBs converted 
into DSBs upon collision with the replication fork are substrates for HR (Kouzminova 
and Kuzminov 2006, Kuzminov 2001). 
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1.2.10  Single-Strand Breaks and Transcription 
 
The continuing function of a cell depends on the unperturbed transcription of the coding 
regions of the genome and therefore DNA lesions within these transcribed regions of the 
genome can result in a number of deleterious effects. Transcribing past the damage can 
result in mutations due to incorrect base insertion opposite the lesion, the presence of the 
lesion can affect the rate of transcription, altering the expression level of the damaged 
gene, and finally transcription can be completely blocked, leading to loss of the 
transcript (Zhou and Doetsch 1994, Tornaletti 2009). 
 
The existence of dedicated repair pathways, termed transcription-coupled repair (TCR), 
to recognise and repair transcription-blocking lesions is well established (Tornaletti 
2009, Nouspikel 2009, Lagerwerf et al. 2011). Human disorders, such as the 
microcephalic cockayne syndrome, which are associated with defects in the repair of 
DNA lesions in transcribed genes, highlight the cytotoxicity of unrepaired transcription-
blocking lesions (Lehmann 2003). Cyclobutane pyrimidine dimers (CPD) and 
intrastrand crosslink are confirmed transcription-blocking lesions that can be repaired by 
TCR. There is evidence that SSBs can also block RNA polymerases and that SSBR has 
a role in protecting against transcription-blocking DNA damage. 
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Upon collision with transcription machinery Top1 cleavage complexes convert into 
abortive Top1-SSBs (Kroeger and Rowe 1989, Wu and Liu 1997). A significant portion 
of the accumulating abortive Top1-SSBs seen in TDP1-defective cell lines following 
incubation with camptothecin (CPT), a Top1 poison that increases the half-life of Top1 
cleavage complexes, is dependent on the presence of active transcription as 
demonstrated by their disappearance following incubation with the RNA polymerase 
inhibitor α-amanitin (Miao et al. 2006, El Khamisy et al. 2005). Moreover, CPT-induced 
SSBs still accumulate in TDP1-defective cell lines in the presence of the replication 
inhibitor aphidicolin showing that TDP1-dependent SSBR has a role in protecting the 
cell against transcription blocking lesions (Miao et al. 2006, El Khamisy et al. 2005). 
Furthermore, the DNA glycosylase NEIL2 has also been shown to associate with RNA 
polymerase II and to preferentially repair oxidised bases within transcribed genes, 
further supporting a role for SSBR in the repair of transcription-blocking lesions 
(Banerjee et al. 2011). 
 
 
1.3  DNA Double-Strand Breaks 
 
DNA double strand breaks (DSB) are discontinuities in both strands of the DNA double 
helix and may arise from both endogenous and exogenous sources. Although these 
lesions are rare: only ten DSBs are estimated to arise per cell per day based on 
experiments performed on early passage primary human fibroblasts (Lieber et al. 2003, 
Lieber and Karanjawala 2004, Martin et al. 1985), DSBs are considered to be 
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particularly genotoxic. A single unrepaired DSB can be sufficient to induce apoptosis 
(Rich, Allen, and Wyllie 2000). Failure to repair these breaks correctly can lead to 
chromosomal rearrangements, including translocations and deletions, chromosomal mis-
segregation during mitosis and/or cell death (Hoeijmakers 2001). 
 
DSBs can be generated directly by the formation of two direct SSBs nearby but on 
opposite strands, by ionizing radiation or radiomimetic chemicals. Free radical attack of 
the sugar-phosphate backbone of the DNA double helix results in the disintegration of 
two closely located oxidised sugars on anti-parallel DNA strands (Ward et al. 1987, 
Limoli et al. 1998).  
 
Ionising radiation is a major source of DSBs as the IR particles create localised clusters 
of ROS as they pass through the cell, mostly from water, increasing the chance that two 
closely spaced lesions will arise. Indeed, whilst hydrogen peroxide induces one DSB for 
every ~2000 SSBs, IR generates one DSB for every 25 - 40 SSBs (Ward et al. 1987, 
Limoli et al. 1998). Endogenous DSBs can arise from a number of sources; as the result 
of the abortive activity of  type II DNA topoisomerases which transiently nick both 
strands of the duplex in nearby loci, by the collision of a replication fork with a SSB 
during DNA replication, or from mechanical stress on chromosomes such as during 
chromosomal segregation in mitosis (Adachi et al. 2003, Kuzminov 2001, Hoeijmakers 
2001, Kouzminova and Kuzminov 2006). 
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1.3.1  DNA Double-Strand Break Repair 
 
The efficient repair of double strand breaks is of prime importance for the maintenance 
of genomic integrity. DNA double strand break repair can be divided into two major 
sub-pathways: Non-Homologous End Joining (NHEJ) and Homology Directed Repair 
(HDR). These pathways involve different repair complexes, have different levels of 
repair rate and fidelity and take place preferentially at different stages of the cell cycle. 
 
1.3.2  Double-Strand Break Signalling 
 
DSB detection, signal transduction and activation of checkpoints in controlled by two  
crucial kinases, ATM and ATR. ATM detects DSBs and disruptions in chromatic 
structure, whereas ATR acts primarily in response to stalled replication forks. Both 
kinases phosphorylate downstream targets in a signal transduction cascade, eventually 
leading to cell cycle arrest (Bakkenist and Kastan 2003, Goodarzi et al. 2006). 
 
ATM belongs to a family of serine-threonine kinases, which possess structural 
homology to phosphoinositide I (PI3) kinases, known as the PI3 kinase-like-kinase 
(PI3KK) family which include DNA PK, and plays an important role in the coordination 
of events that take place during DSBR (Abraham 2004). ATM is rapidly recruited to 
DSBs whereupon it phosphorylates serine 139 on the histone variant H2AX to produce 
γ-H2AX (Burma et al. 2001). ATM activity is partially dependent on the presence of 
MRN, another DSB sensor that is believed to act in concert with ATM to promote 
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efficient DSBR (Uziel et al. 2003, Lavin 2007, Williams, Williams, and Tainer 2007). 
 
Upon formation of γ-H2AX, the mediator of DNA damage checkpoint protein 1 
(MDC1) is recruited to the break, is phosphorylated by ATM, and binds to the 
phosphorylated histone (Manuel Stucki and Jackson 2004; Lukas et al. 2004), where it is 
thought to acts as a protein platform to help stabilise DDR proteins at the lesion. It also 
acts to propagate the γ-H2AX signal by recruiting more ATM to the break via its FHA 
domain, which then phosphorylates H2AX further away from the break to produce more 
γ-H2AX (Lou et al. 2006). H2AX phophorylation can spread for up to 2 megabases 
either side of the DSB, which is important for orchestrating the DDR (Celeste et al. 
2002; Harper and Elledge 2007). 
 
A cascade of ubiquitin modification at DSB sites signals recruitment of many more 
effectors of the DDR. The E3 ubiquitin ligase ring finger protein 8 (RNF8) interacts 
with phophorylated MDC1 at the break and ubiquitinates H2A and γ-H2AX in the 
vicinity of the break (Huen et al. 2007, Kolas et al. 2007, Mailand et al. 2007). A second 
and third E3 ligase are then recruited - RNF168 and HERC2, to stimulate further 
ubiquitination (Doil et al. 2009; Grant S Stewart et al. 2007). The spreading ubiquitin 
chains promote the recruitment of RAP80, BRCA1 and 53BP1 (Huen et al. 2007; Kolas 
et al. 2007; Lavin 2008). 53BP1 plays an important role in the DDR although it is not 
yet clearly understood. Cells from patients with loss-of-function mutations in ATM do 
not arrest at the S phase checkpoint following irradiation (Painter 1981) and are 
consequently hypersensitive to it (Littlefield et al. 1981). 
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1.3.3  Non-Homologous End Joining 
 
NHEJ is the primary method of DSBR in non-proliferating or G1-phase cells (Takata et 
al. 1998). It is high-fidelity DSBR pathway and since NHEJ does not require a 
homologous sequence for accurate repair it operates throughout the cell cycle and is of 
particular importance during G0, G1 and early S-phase when a sister chromatid is not 
available for use as a template (Takata et al. 1998, Sonoda et al. 2006, Delacôte and 
Lopez 2008).  
 
Classical NHEJ 
The poly (ADP) ribose polymerase protein PARP3 is activated upon detection of a 
break, ribosylating itself and other substrate proteins such as histones to signal the break 
(Rulten et al. 2011). Ku70/80 heterodimers rapidly bind both ends of the DSB and form 
a ring-like structure that encircles the DNA and translocates along the strands, making 
the ends of the DNA accessible for recruitment of DNA-dependent protein kinase 
catalytic subunit (DNA PKcs), which in concert with Ku and DNA forms the active 
holoenzyme DNA PK (Jin et al. 1997, Uematsu et al. 2007, Suwa et al. 1994). XRCC4, 
the scaffolding protein, facilitates recruitment of repair factors and provides a platform 
for the activated DNA PK to align the broken ends and form a 'synaptic complex' 
(DeFazio et al. 2002). The synaptic complex acts to tether the ends of the DSB to each 
other and to offer protection against unwanted processing by nucleases. The assembly of 
the DNA PKcs/Ku/DSB synaptic complex also stimulates the serine/threonine protein 
kinase activity of DNA PK. Among other proteins, it also targets itself - causing a 
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conformational change that allows end-processing enzymes to access the ends of the 
double-strand break (Meek et al. 2007).  
 
The next stage of NHEJ is the processing of the DNA termini at the ends of the DSB to 
restore ligatable 3'-OH and 5'-P termini. Like SSBs, DSBs can have a multitude of 
different chemistries at the DNA ends, depending on the source of the damage, and 
therefore require a diverse set of end-processing enzymes for repair. The Werner protein 
(WRN) plays an important role here - highlighted by the clinical manifestation of the 
progeroid syndrome, Werner syndrome - wherein the protein cannot be appropriately 
transported to the damage site (Delacôte and Lopez 2008). Artemis is a key NHEJ end 
processing factor that is reported to possess a number of different repair activities, 
including 5' -> 3' exonuclease and 3'-PG processing activity as well as the ability to 
resolve DNA hairpins (Goodarzi et al. 2006, Ma et al. 2002). Artemis is recruited to 
DSBs via an interaction with DNA PKcs, and is only activated for end-processing upon 
phosphorylation by the DNA damage inducible protein kinase ataxia telangiectasia 
mutated (ATM) (Ma et al. 2002, Goodarzi et al. 2006). ATM and ataxia telangiectasia 
and Rad3-related (ATR) are serine/threonine protein kinases that signal DNA damage 
and activate the DNA damage checkpoint, leading to cell-cycle arrest during repair. 
 
PNK also interacts with CK2-phosphorylated XRCC4 and it is believed to perform a 
similar end processing role in NHEJ as it does in SSBR (wherein it interacts with 
XRCC1) (Limoli et al. 1998, Chappell et al. 2002, Segal-Raz et al. 2011; Bernstein et al. 
2005, Koch et al. 2004, Mani et al. 2010). Aprataxin has also been implicated in DSBR. 
50 
 
It interacts with CK2-phosphorylated and XRCC4 and has been shown to remove 
adenylate groups from the 5' termini of both SSBs and DSBs in vitro (Clements et al. 
2004, Rass, Ahel, and West 2007). 
 
Another end-processing factor that has been implicated in NHEJ is tyrosyl-DNA 
phosphodiesterase 2 (TDP2), a protein that resolves damage arising from abortive 
topoisomerase 2 (Top2) activity. Top2 induces DSBs as part of a reaction to relax DNA 
supercoils. This reaction mechanism involves formation of an intermediate in which the 
topoisomerase is covalently linked to the 5' terminus of the break via a phosphotyrosyl 
bond (Wang 2002, Nitiss 2009). Normally this is a very transient intermediate and the 
DSB is rapidly resealed in the final stage of the reaction, but under certain 
circumstances, such as in the presence of Top2 poisons like etoposide, a stable DSB 
with 5'-Top2 may persist. Tdp2 is a recently identified phosphodiesterase that cleaves 5'-
phosphotyrosyl bonds and has been shown to repair Top2-DSBs (Zeng et al. 2011).  
 
DSB processing can lead to deletions and gaps in the code, which require filling by a 
DNA polymerase. The X family of DNA polymerases have been implicated in carrying 
out gap-filling during NHEJ, including polymerases μ and λ, which interact with Ku and 
XRCC4/LigIV, and terminal deoxyribonucleotidyltransferase (TdT), which interacts 
with Ku, (Nick McElhinny et al. 2000, Mueller et al. 2008). 
 
Once the DNA termini have been processed, and any gaps have been filled, the final 
step in NHEJ is to reseal the strands. Ligation of the DSB is carried out by DNA LigIV 
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in a complex with XRCC4 (Critchlow, Bowater, and Jackson 1997, Grawunder et al. 
1997, Grawunder et al. 1998).  The recruitment and stability of XRCC4-LigIV at the 
DSB is mediated by interactions with Ku70/80, DNA PK and the ADP-ribose binding 
protein, aprataxin and PNK- like factor (APLF) (Mehrotra et al. 2011; Rulten et al. 
2011; Rulten et al. 2008; Macrae et al. 2008; Calsou et al. 2003; McElhinny et al. 2000). 
XRCC4 –like factor (XLF) is another factor recruited to DSBs via an interaction with 
Ku70/80 and functions to stimulate NHEJ (Ahnesorg, Smith, and Jackson 2006, Yano et 
al. 2008). XLF is similar in structure to XRCC4 and facilitates rapid end-joining by 
stimulating DNA ligation and promoting the re-adenylation of LigIV following ligation 
(Gu et al. 2007, Riballo et al. 2009, Hammel et al. 2011). An overview of classical 
NHEJ is shown in Figure 1.16.  
 
Mutation or suppression of classical NHEJ proteins has serious consequences in 
mammals. Mutations in DNA-PKcs can cause defective V(D)J recombination and 
arrested B- and T- lymphocyte development in severe combined immune-deficient 
(SCID) mice (Finnie et al. 1996, Blunt et al. 1995). Interestingly, this defect can be 
partially rescued by radiation treatment or radiomimetic drugs, possible by activation of 
alternative double strand break repair mechanisms (Danska et al. 1994, Murphy et al. 
1994). Deletion of PARP1 (one function of which is to suppress recombination) rescues 
lymphocyte development in the SCID mouse (Morrison et al. 1997). This suggests that 
elevated levels of recombination in the absence of PARP1 aid V(D)J recombination in 
the absence of DNA-PK activity (Morrison et al. 1997, Chatterjee, Berger, and Berger 
1999). 
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Consistent with this, an alternative NHEJ pathway involving PARP1, XRCC1, and 
DNA ligase III-α has been proposed (Audebert, Salles, and Calsou 2004). Recombinant 
PARP1, XRCC1 and DNA ligase III-α are able to repair DNA double strand breaks with 
blunt or 5' or 3' recessed termini in vitro. Exclusion of any of these proteins abolished 
repair activity indicating that all three proteins are required (Audebert, Salles, and 
Calsou 2004). 
 
1.3.4  Homology Directed Repair 
 
Repair pathways that utilize a homologous sequence from an undamaged DNA template 
to repair a DSB are known collectively as homology-directed repair (HDR) (Figure 
1.17) (Hartlerode and Scully 2010; Pâques and Haber 1999). These repair mechanisms 
are of prime importance during the late S and G2 phases of the cell cycle owing to the 
presence and proximity of sister chromatids (Delacôte and Lopez 2008; Sonoda et al. 
2006). 
 
The Mre11-Rad50-NBS1 (MRN) complex is critical in the early response to DSBs 
leading to HDR (Williams, Williams, and Tainer 2007). Amongst its many other roles, it 
is thought that two MRN complexes carry out a similar function during HDR to the 
DNA PKcs/Ku/DSB synaptic complex during NHEJ, by tethering the ends of a DSB 
together via homodimerisation of the Rad50 subunit (Hopfner et al. 2002, Williams et al. 
2008, Lavin 2007) . Following detection of the break, the DNA ends are resected in a 5'-
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3' direction to generate 3' ssDNA overhangs with a 3'-OH terminus. MRN, in concert 
with CtIP, has been shown to initiate DNA resection by trimming the DNA ends (Sartori 
et al. 2007; Huertas and Jackson 2009; Coleman and Greenberg 2011, Mimitou and 
Symington 2008). End resection is then mostly carried out by two nucleases, DNA2 and 
EXO1, in combination with the helicase BLM (Z. Zhu et al. 2008; Mimitou and 
Symington 2008). BRCA1 has also been implicated in the regulation of DNA resection 
(Coleman and Greenberg 2011). 
 
The ssDNA generated by resection is rapidly bound by the ssDNA binding protein RPA 
which melts the DNA secondary structure (Sung and Klein 2006). RPA is then displaced 
from the ssDNA by the Rad51 recombinase via mediator proteins BRCA1/BARD1 and 
BRCA2/DSS1 to form a Rad51 nucleofilament,  which carries out the strand invasion 
and homology search steps of HDR (Wong et al. 1997, Pellegrini et al. 2002, San 
Filippo et al. 2006). Strand invasion involves capture of the intact duplex by the Rad51 
nucleofilament which forms a D-loop intermediate, where the 3' termini of the invading 
strand is primed for DNA synthesis. It is at this point that the various theoretical 
pathways of HDR diverge. 
 
In the homologous recombination (HR) pathway, the resected second DNA end is 
captured by the migrating D-loop, forming a double Holliday Junction (HJ) (Pâques and 
Haber 1999, Hartlerode and Scully 2010). These double HJs are then resolved 
enzymatically by a number of structure-specific endonucleases (Wu and Hickson 2003, 
Chen et al. 2001, Rass et al. 2010). Depending on the orientation of resolution this can 
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lead to either a crossover or non-crossover event (Pâques and Haber 1999, Hartlerode 
and Scully 2010). In the synthesis-dependent strand-annealing pathway (SDSA), 
following DNA synthesis and D-loop migration, the newly synthesised invading strand 
is displaced and anneals back to the second resected end of the break (Pâques and Haber 
1999, Hartlerode and Scully 2010).  
 
Single-strand annealing (SSA) is an error prone HDR pathway that takes place when a 
DSB arises between two direct repeats (Pâques and Haber 1999, Hartlerode and Scully 
2010).  Resection exposes the repeats, generating two complementary single strands that 
anneal together. The resulting DNA flaps generated are excised and the DNA nicks are 
ligated by ligase IV (McElhinny et al. 2000). 
 
Finally, break-induced recombination (BIR) proceeds when a one-ended DSB invades 
the intact duplex, forming a recombination induced replication fork (Paques and Haber 
1999, Hartlerode and Scully 2009). This may be a particularly important repair pathway 
during DNA replication as a way of restarting a collapsed replication fork caused when 
an elongating fork collides with a SSB (Kuzminov 2001). 
 
1.4    DNA Damage Response in Ageing and Disease 
 
The processes of DNA repair are not perfect and over time unrepaired or misrepaired 
damage accumulates in the genome. In non-dividing cells, DNA damage accumulation 
may lead to cell death or loss of gene expression and impaired cell function. The 
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accumulation of unrepaired DNA damage is most pronounced in long-lived non-
replicating or slowly replicating cells, such as neurons, skeletal and cardiac muscle 
(Barzilai 2007, Caldecott 2008).  In dividing cells, accumulation of DNA damage may 
additionally lead to mutations; resulting in function impairment, cell death or cancer. 
The deleterious consequences of persisting DNA damage, have already been outlined, 
and will be discussed in more detail in terms of human pathology in Section 1.5. But it 
is worth noting that the inherent imperfections of the DDR are critical in driving two 
fundamental forces of biology; evolution (of the species) and ageing (of the individual).  
 
Evolution 
When DNA damage is left unrepaired, or is repaired erroneously, a mutation may result 
(e.g. Figure 1.8). In dividing cells, mutations may propagate into the genome of the 
cell‟s progeny. When mutations occur in a germ line cell, then the mutation may be 
passed on to gametes and the organism‟s offspring. Mutations may either: 
a)  have no effect  
b)  alter the gene product 
c)  prevent the gene from functioning 
When mutations change the gene product, the outcome will most often be deleterious or 
neutral. But occasionally the change may be beneficial, conferring a 
survival/reproductive advantage to the host, and favouring the propagation of their 
genetic material over that of their competitors by the processes of natural selection 
(Darwin and Peckham 1959). 
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Mutations can involve large sections of a chromosome becoming duplicated (i.e. by a 
recombination event), which can introduce extra copies of a gene into a genome. Extra 
copies of genes are the raw material by which new genes evolve (Lynch and Conery 
2000, Hughes 2002). Hence we can see evidence of gene families in which many 
divergent genes descend from a single ancestral gene (i.e. the histidine triad (HIT) 
family of nucleotide hydrolases and transferases, of which aprataxin is a member)(Date 
et al. 2001, Moreira et al. 2001). 
The rate of evolution in a species, or a gene, is a function of the rate of mutation. 
Consequently, the rate and accuracy of DNA repair mechanisms have an influence over 
the process of evolutionary change (Maresca and Schwartz 2006). Evolution allows a 
species to adapt to environmental changes in order to survive and reproduce.  
 
Ageing 
Whilst ageing typically involves many deleterious effects it also has several benefits at 
the level of the individual and the population. Ageing is synonymous with senescence at 
both the cellular and the organismal level: i.e. the cell/organism broadly switches from a 
“growth” phase to a “maintenance” phase. At the expense of rapid cell turnover and 
growth, slower and more precise repair mechanisms are employed to preserve function 
(Hoeijmakers 2007). At the level of the whole organism, diminishing fertility with age 
in mammals means that reproduction generally takes place while the adult is able to 
support their young, and in modern humans the emergence of the late adulthood age 
group is accredited with the development of human culture as it permits the clear 
transmission of information from one generation to another, and the division of labour 
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such as childcare, and crop cultivation (Caspari and Lee 2004). Hence, the biological 
processes involved with ageing protect genomic integrity and benefit populations. 
Eventually though, these systems start to fail and age-related disease emerge. 
The cellular compartment, part of the chromosome and nature of DNA lesion most 
associated with age-related disease will be briefly discussed in order to highlight their 
importance with respect to neurological disease. 
 
1.4.1  Mitochondria 
 
Mitochondrial DNA (mtDNA) seems to be more susceptible to DNA damage and 
consequently sustains higher mutation rates (an estimated ten times higher) than nuclear 
DNA (nDNA). Several factors may contribute for the heightened damage susceptibility 
including exposure to high levels of reactive oxygen species produced during oxidative 
phosphorylation, lack of protective histones, and a limited capacity for DNA repair 
(Beal 1996, Croteau and Bohr 1997, Lightowlers et al. 1997). The tissues most 
associated with age-related degeneration (neurons and skeletal/cardiac muscle) are those 
with the most mitochondria. Both inherited and somatic mitochondrial mutations are 
associated with a wide variety of degenerative disorders and cancers (Wallace, 1994, 
Wallace, 2001). 
In mice, when catalase expression is increased in mitochondria, oxidative damage in 
skeletal muscle is decreased and lifespan is extended by around 20% (Schriner et al. 
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2005, Linford, Schriner, and Rabinovitch 2006), suggesting that mitochondria are a 
significant source of the oxidative damages contributing to ageing. 
 
1.4.2  Telomeres 
 
The ends of eukaryotic linear chromosomes are double stranded discontinuities that 
must be protected from the processes of DSBR. Telomeres are specialized DNA-protein 
structures that cap the ends of chromosomes (McEachern, Krauskopf, and Blackburn 
2000), thereby protecting them from degradation by nucleases and replicative stress, and 
fusion by cellular DNA repair processes (Figure 1.18) (Rodier et al. 2005). Functional 
telomeres are essential for maintaining the integrity and stability of genomes (Blackburn 
1990). In vertebrate cells, telomeres consist of several kilobase pairs of non-coding 
DNA tandem repeats of the sequence TTAGGG, a few hundred base pairs of single-
stranded DNA at the 3' end of the telomeric DNA tract, and a host of proteins that 
organize the telomeric double and single-stranded DNA into a protective three 
dimensional structure (Rodier et al. 2005).  
 
The terminal non-coding telomeric DNA whose presence stabilizes chromosomes was 
first reported the best part of a century ago (Muller 1938, McClintock 1941). Over the 
last four decades, much work has been undertaken to understand the structure, function 
and biological impact of telomeres. In 2009 Drs Elizabeth Blackburn, Jack Szostak and 
Carol Greider won a Nobel Prize for their work on how chromosomes are protected by 
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telomeres and the enzyme telomerase (Nobel Prize, 2009). 
 
DNA polymerases replicate DNA in the 5'→ 3' direction, and are unable to start DNA 
synthesis de novo, so with each round of replication, the lagging strand contains a 3' 
single stranded DNA overhang. Thus DNA-dependent RNA polymerase is used to 
synthesize an 8 to 12 bp stretch of RNA primer annealed to the 3'single stranded DNA 
that is able to prime DNA synthesis of 'Okazaki fragments' from its 3' hydroxyl end 
(Okazaki et al. 1968). The RNA primer is later removed and filled by a DNA 
polymerase (Rossi and Bambara 2006).  However, there remains a small overhang at 
extreme 3' ends because the placement of the RNA template leaves at least a 8-12 bp 
gap from the end of the strand (Figure 1.19).  Without replenishment of the non-coding 
telomeric 'buffer' DNA, over continuous rounds of replication the ends of chromosomes 
would progressively shorten and genomic information would be lost (Saldanha, 
Andrews, and Tollefsbol 2003). This is known as the 'End Replication Problem' and is 
solved by telomerase - a reverse transcriptase that performs this telomere replenishment 
role (Greider and Blackburn 1985; Blackburn 1990). 
 
 Telomerase is a ribonucleoprotein complex that extends the 3' single strand overhang 
with TTAGGG repeats using an RNA template (Greider and Blackburn 1985). The 
lagging strand is then filled in by DNA polymerase-α, which contains a DNA primase 
(which synthesized the RNA primer complementary to the new 3'single strand 
overhang) as one of its subunits (Lee et al. 2006) (Figure 1.19). With each cell cycle 
about 50-150 base pairs of terminal DNA is still necessarily lost, leading to 
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progressively shortened 5' termini in the daughter strand (Sozou and Kirkwood 2001). 
Without telomeres, the progressive shortening of the chromosome would lead to rapid 
loss of DNA sequence, and genomic instability - a common cause and hallmark of 
cancer (Gray and Collins 2000). Progressive shortening of the non-coding telomeres acts 
as a cellular clock and is associated with ageing (Vijg and Dollé 2002). As such, 
appropriate telomere maintenance represents a balance between ageing and cancerous 
growth. 
 
Defective telomere maintenance and stability is associated with numerous diseases 
including pulmonary fibrosis, liver disease and progerias (Armanios 2009). Persisting 
oxidative DNA damage has been proposed as one cause of telomere instability (Satoh et 
al. 2008, von Zglinicki 2002). 
 
1.4.3  Oxidative DNA Damage, Prevention and Repair 
 
In addition to the mechanisms of the DNA damage response, elegant physical and 
enzymatic methods exist to protect the genomic information from corruption. Oxidative 
DNA damage is a focus of this thesis and provides an excellent example of these DDR-
independent protection mechanisms. I will discuss the main aspects of oxidative DNA 
damage prevention and repair here. A detailed review of the subject is provided by 
(Slupphaug 2003).  
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Dysruption to the normal redox balance in cells leads to toxic effects. Peroxides and free 
radical intermediates of oxidative metabolism cause damage to proteins, lipids and DNA. 
Oxidative stress reflects an imbalance in favour of the accumulation of reactive oxygen 
species and damages sustained by them, over a biological system's capacity to neutralise 
them and/or repair the damage they cause.  
 
Reactive oxygen species (ROS) such as superoxide anions, OH radicals and hydrogen 
peroxide can induce a large variety of oxidative DNA lesions (Figure 1.20) (Cadet 2003, 
Sander et al. 2005, Beckman and Ames 1997). Endogenous ROS are generated during a 
number of cellular processes. For example during the electron transfer chain, when 
"leaked" electrons encounter oxygen, during the immune response, when phagocytic 
cells produce an oxidative "respiratory burst" to kill virally or bacterially infected cells, 
and during lipid peroxidation in peroxisomes (Beckman and Ames 1997, Cooke et al. 
2003).  
 
Superoxide radical (O2
.-
), hydroxyl radical (OH
.
) and hydrogen peroxide (H2O2) are all 
products of redox cycling in cells that may damage DNA (Figure 1.21). The large 
amount of ROS generated by the cell means that a high level of oxidative DNA damage 
can be measured in normal tissues at any time. The most common damaged purine 
produced is 7,8-dihydro-8-oxoguanine (8-oxo-G), while the most common damaged 
pyrimidine produced is thymine glycol (Tg) (Figure 1.7). More than 20 different types 
of base damage have been identified following exposure to oxidative stress (Slupphaug 
2003). The most prevalent of these are shown in Fig. 1.20.  
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Most indirect SSBs arising as intermediates of the base excision repair pathway (BER) 
are caused by ROS-induced base damage (ie 8-oxo-G) and are generally a single 
nucleotide gap with "damaged" DNA termini. These are termini with chemistries that 
differ from the conventional 3'OH and 5'P moieties that are required for DNA ligation. 
An estimated 70% of 3' termini at ROS-induced SSBs feature a 3'-phosphate and an 
estimated 30% feature a 3'PG. The 5' termini of these SSBs is generally an undamaged 
5' – phosphate although a small percentage feature a 5'-hydroxyl (Limoli et al. 1998, 
Caldecott 2001). 
 
The first line of defence against ROS is enzymatic inactivation of superoxide by 
superoxide dismutase (SOD), in which two superoxide radicals and two protons 
generate the less toxic hydrogen peroxide and oxygen. Hydrogen peroxide is then 
converted to water and oxygen by catalase (Figure 1.21 a). SOD activities are present in 
the mitochondria, nuclei, and extracellular matrix. Three species, SOD1 (also known as 
CuZn-SOD), SOD2 (also known as Mn-SOD) and SOD3 (also known as EC-SOD) have 
been identified in humans. SOD1 and SOD3 are clearly related and thought to have a 
common ancestor, while SOD2 is structurally very different and may have a different 
origin. SOD1 is a cytoplasmic enzyme, SOD2 is mitochondrial and SOD3 is 
extracellular. Mutations in SOD1 are associated with familial amyotropic lateral 
sclerosis. The SOD1
G93A
 mutant causes toxic elevation of ROS levels in cells. The 
SOD1
G93A
 mutant is understood to exert its oxidative damage to DNA by the conversion 
of hydrogen peroxide to highly toxic hydroxyl radicals by way of these Fenton-type 
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reactions (Mao et al. 1993) (Figure 1.21 b), and is used to model ALS in mice (Gurney 
et al. 1994, Gurney 1997, Howland et al. 2002, Barbosa et al. 2010). Mice with targeted 
disruption of the SOD2 gene develop lethal cardiomyopathia, demonstrating the 
importance of these enzymes in vertebrates (Zelko, Mariani, and Folz 2002, Fang, Yang, 
and Wu 2002).  
 
Many other factors contribute to the defence against ROS and cellular consequences of 
ROS, including antioxidant amino acids (e.g. arginine) and vitamins (e.g. Vitamins A,C 
and E), thiols (especially glutathione), tea polyphenols, enzyme-bound minerals (e.g. 
selenium and zinc) and antioxidant enzymes (e.g. glutathione reductase, glutathione 
peroxidases) (Fang, Yang, and Wu 2002, Slupphaug 2003). Secondly, enzymes such as 
8-oxo-dGTP, hydrolyse oxidised dNTPs to the corresponding dNMP, preventing the 
potentially mutagenic incorporation of a damaged base into nascent DNA (Slupphaug 
2003). Finally, several DNA repair mechanism resolve oxidative damage. BER is the 
primary oxidative damage repair pathway, while TCR and MMR provide important 
backup pathways for repair of transcribed and newly replicated strands, respectively 
(Slupphaug 2003). 
 
 
1.5 DNA Damage Response Defects and Human Genetic 
Disease 
 
As described above, the wide array of DNA lesions that arise in cells are repaired by 
numerous overlapping DNA repair pathways in order to maintain genome integrity. The 
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importance of each repair pathway to human health is highlighted by the existence of 
human genetic disease which are caused by defects in these pathways. Three main 
classes of symptoms are associated with defective DNA damage response mechanisms 
are i) predisposition to cancer ii) deficiencies in the immune system, and iii) deficiencies 
in the nervous system (Hoeijmakers 2001, Hoeijmakers 2007, Jackson and Bartek 2009, 
McKinnon and Caldecott 2007, McKinnon 2009). 
Cancer is a family of diseases arising from genomic instability (Negrini and Calin 2010).  
DNA damage leading to mutation can cause the loss of tumour-suppressor genes or the 
improper activation of oncogenes, triggering malignancy and uncontrolled cellular 
proliferation (Hoeijmakers 2001). Several lymphoid tumours are associated with 
specific chromosomal translocations involving proto-oncogenes (Schlissel, Kaffer, and 
Curry 2006). Defective DNA damage response results in an elevated mutation rate, 
known as a 'mutator phenotype', such as that resulting from inherited defects in MMR 
and leading to a predisposition to colorectal and endometrial carcinomas (Hoeijmakers 
2001, Jiricny 2006). Moreover, the fact that most carcinogens are DNA damaging 
agents, or otherwise affect the DDR, further highlights the link between DNA damage 
and cancer. 
 
Defects in countless other DDR pathways have been implicated in the aetiology of 
cancer. Defects in the global genome NER pathway leads to a pronounced UV-
sensitivity and a high incidence of skin cancer (Lehmann et al. 1975). Mutations in 
numerous proteins in the DSB signalling cascade, such as ATM and Nbs1, also impart 
susceptibility to cancer. 
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The link between DNA repair defects and immunodeficiency is due to essential roles 
specialised DNA repair pathways have in the development of the vertebrate immune 
system (Dudley et al. 2005). Multiple DNA repair pathways are involved in class switch 
recombination, a specialised DNA repair pathway involved in the production of 
antibodies (Dudley et al. 2005). 
In addition, members of the NHEJ pathway play crucial roles in the production and 
diversification of the antigen receptors expressed on B- and T- lymphocytes in a 
pathway called V(D)J recombination (Hartlerode and Scully 2010) and various 
immunodeficient human disorders are caused by mutations in proteins involved in this 
pathway. Deficiencies in ATM, Mre11, XLF, RNF168, Ku70/80, LigIV and Artemis are 
all associated with severe immunodeficiency disorders (Chun and Gatti 2004, Stewart et 
al. 2007; Zhu et al. 1996, Bohgaki et al. 2011, Uziel et al. 2003, Goodarzi et al. 2006). 
 
Finally, defective DNA response can also result in disorders of the nervous system. 
There are two main classes of neuropathology that are linked to defective DNA repair; 
primary microcephaly and progressive neurodegeneration (McKinnon 2009, O‟Driscoll 
and Jeggo 2008). Primary microcephaly is a clinical term, which is used to describe an 
abnormally small head size - defined as head circumference 3 standard deviations below 
the mean, apparent from birth (O‟Driscoll and Jeggo 2008). The underlying cause of the 
reduced head circumference is a reduction in total brain volume, as the outward pressure 
of the developing brain is the driving force for the growth of the head and skull. An 
early period of rapid proliferation of neuronal progenitor cells in the ventricular (VZ) 
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and subventricular zones (SVZ) that line the ventricles of the developing brain is critical 
for the development of the myriad neurons that comprise the mature nervous system 
(Bayer et al. 1991, Chan et al. 2002). Once these neuronal progenitors have replicated, 
cells destined to become neurons exit the cell cycle, differentiate and migrate away from 
the VZ and SVZ, towards the cortical plate (Bayer et al. 1991, Chan et al. 2002, 
Carmichael and Woods 2006). Due to the rapid proliferation that the neuronal 
progenitors undergo, they are heavily reliant on efficient DNA repair pathways to 
resolve replication-associated DNA damage (Barnes et al. 1998, Gao et al. 2011). 
 
Additionally, these neuronal progenitors also have a relatively low threshold of DNA 
damage that is required to induce apoptosis (Hoshino and Kameyama 1988, Hoshino, 
Kameyama, and Inouye 1991). Therefore defects in DNA repair are believed to lead to 
an elevated rate of apoptosis in the proliferating progenitors due to persisting replication 
stress-induced damage, and a diminished total number of neurons in the developing 
brain and consequential microcephaly (Gatz et al. 2011). 
  
Microcephaly is a common feature amongst defective DNA repair disorders, with 
defects in NHEJ, NER, SSBR, and MRN-dependent DSB signalling all leading to 
microcephalic disorders (Lehmann 2003, Shen et al. 2010, O‟Driscoll et al. 2001). The 
other type of neuropathology that can arise from defective DNA repair is the progressive 
neurodegeneration of the brain. Neurodegenerative disorders usually present sometime 
after birth and are typically associated with the progressive degeneration of specific 
regions of the brain such as the cerebellum (Date et al. 2001, Moreira et al. 2001). The 
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progressive degeneration of the adult brain is thought to be due to the accumulation of 
DNA lesions in post mitotic cells. Neurons are highly active cells and generally exhibit 
high levels of mitochondrial respiration, and also have a reduced capacity to neutralise 
reactive oxygen species, resulting in elevated levels of oxidative DNA damage in 
neurons (Barzilai 2007, Weissman et al. 2007). 
Furthermore, the adult brain has a limited capacity for cellular regeneration and since 
post mitotic neurons remain in the G0 phase of the cell cycle, they lack the DNA repair 
pathways that operate during S-phase and G2, such as HR (Rass, Ahel, and West 2007a). 
Hence the brain is exquisitely sensitive to repair defects as the usual backup 
mechanisms are not present. Accumulated DNA lesions may result in disruption to 
transcription, loss of cell functionality and/or apoptosis (Lagerwerf et al., 2011). Defects 
in NER, SSBR, and ATM- and Mre11-dependent DSB signalling, and can all result in 
disorders characterised by progressive neurodegeneration of the cerebellum (Barbot et 
al., 2001, Chun & Gatti, 2004, Date et al., 2001, Lavin, 2008, Stewart et al., 1999). 
 
1.5.1  DNA Damage Response Defects and Neurological Dysfunction 
 
As the brain is largely protected from exogenous DNA damage sources by the cranium 
and the blood-brain barrier, DNA lesions in the brain result predominantly from 
endogenous sources. The high rate of oxidative metabolism in the brain and the resulting 
high concentrations of reactive oxygen species produces high levels of DNA damage, 
especially single-strand breaks and oxidative damage (De Bont 2004, Lindahl 1993). 
Robust DNA repair processes are generally associated with replication in proliferating 
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cells (Barnes and Lindahl 2004). The absence thereof in the post-mitotic neurons makes 
them more reliant on the functioning repair mechanisms at their disposal - and 
exquisitely sensitive to loss of functionality therein.  
 
 
1.5.2  Autosomal Recessive Cerebellar Ataxias 
 
Autosomal recessive cerebellar ataxias (ARCAs) are a group of rare neurological 
disorders, which present with ataxia (lack of muscle coordination) and a range of 
opthalmological and neurological symptoms due to cerebellar dysfunction. Amongst the 
many different types of ARCA, a subset are caused by defective DNA damage response. 
These include Ataxia Telangiectasia (A-T), Ataxia Telangiectasia-Like Disorder (A-
TLD), Xeroderma Pigmentosum (XP), Spinocerebellar Ataxia with Axonal Neuropathy 
Type 1 (SCAN) and Ataxia with Oculomotor Apraxia Type 1 and 2 (AOA1 and AOA2).  
 
Ataxia Telangiectasia 
 
Ataxia Telangiectasia (A-T) is the best characterised DNA repair-defective ARCA (1,2) 
and is caused by mutation of the Ataxia Telangiectasia Mutated gene (ATM).  Symptoms 
of progressive cerecellar ataxia present an early age of onset (between 2 and 4 years) 
and patients are normally wheelchair-bound by their teens (Sedgwick, Robins, and 
Lindahl 2006). Oculomotor abnormalities (loss of eye movement control) affects most 
patients (Lewis 1999), and oculocutaneous telangiectasia (blood-shot eyes) generally 
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present between 2 and 8 years. The extraneurological features of AT include a 
predisposition to malignancy – especially leukaemia and lymphoma extreme sensitivity 
to many anti-cancer treatments including radiation and mutagenic chemicals, and 
immunodeficiency. A-T is caused by mutations in the Ataxia-Telangiectasia Mutated 
(ATM) gene, resulting in reduced kinase activity of ATM, or reduced protein stability 
(Lakin et al. 1996).  
 
Ataxia with Oculomotor Apraxia Type 2 
 
Ataxia with Oculomotor Apraxia Type 2 (AOA2) (also referred to as non-Friedrich 
spinocerebellar ataxia type 1 (SCA1)), has a clinical presentation similar to that of 
AOA1 patients. Patients develop a late-onset (11-22 years) progressive cerebellar ataxia 
(Le Ber, Brice, & Dürr, 2006, Moreira et al., 2001) featuring gait ataxia, progressive 
peripheral sensory and motor neuropathy, dysarthria and oculomotor apraxia (Le Ber, 
Brice, and Dürr 2006). AOA2 is not associated with mental impairment or 
predisposition to malignant or infectious disease. AOA2 patients display elevated levels 
of γ-globulin, α-fetoprotein and creatin kinase (Le Ber, Brice, and Dürr 2006). AOA2 is 
caused by mutations in the SETX gene (Moreira et al. 2001), which encodes the putative 
DNA/RNA helicase senataxin. The function of senataxin is not yet clear, but cells from 
AOA2 patients display hypersensitivity to single strand break inducing agents, 
especially hydrogen peroxide (Suraweera et al. 2009) - suggesting a role in DNA repair. 
Recent reports also suggest a role in mRNA processing and transcriptional regulation 
(Suraweera et al., 2009, Yüce-Petronczki & West, 2012). 
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Spinocerebellar Ataxia with Axonal Neuropathy Type 1 
 
Spinocerebellar Ataxia with Axonal Neuropathy Type 1 (SCAN1) is another autosomal 
recessive spinocerebellar ataxia of onset between 12 and 15 years of age. Peripheral 
neuropathy results in the progressive loss of touch and pain sensations in the limbs 
(Takashima et al. 2002). Progressive ataxia results in patients becoming wheelchair-
dependent but unlike A-T, AOA1 and AOA2, oculomotor abnormalities have not been 
reported (Takashima et al. 2002). SCAN1 is caused by mutations in the TDP1 gene, 
which encodes the DNA end-processing factor Tyrosyl-DNA phosphodiesterase, Tdp1. 
This enzyme resolves phospho-tyrosine residues resulting from abortive Topo1 activity 
(Figure 1.6 ). 
 
Ataxia with Oculomotor Apraxia Type 1 
 
Ataxia with Oculomotor Apraxia Type I (AOA1) is an autosomal recessive 
spinocerebellar ataxia (ARCA) (Aicardi et al. 1988). It was initially described as a 
variant form of Friedreich's ataxia (FRDA) and is also referred to as Early Onset Ataxia 
with Hypoalbuminemia (EAOH) (Shimazaki et al. 2002). In contrast to FRDA, patients 
with AOA1 never develop cardiomyopathy, but do develop severe sensory and motor 
neuronopathy, hypoalbuminemia and moderate cognitive impairment. In 2001, the gene 
mutated in AOA1 was identified as APTX, the gene for aprataxin. Incidence and 
prevalence vary markedly among different ethnic groups and geographic areas. 
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Prevalence is highest in Japan, where it is the most common form of ARCA, and second 
highest in Portugal, where it accounts for ~21% of ARCA cases (Barbot et al. 2001).  
 
AOA1 is characterized by three clinical features: i) cerebellar and sensory ataxia and 
involuntary movement ii) ocular motor apraxia (OMA), defined as the impaired 
initiation of saccadic eye movement, accompanied by head thrusts, and iii) sensory and 
motor neuronopathy. These clinical features are accompanied by two biochemical 
markers, hypoalbuminemia and hypercholesterolemia (Le Ber et al. 2003). Gait ataxia 
generally develops in AOA1 patients in the first decade of life. Progressive loss of 
muscle coordination affects balance, movement and speech. Loss of limb control (called 
limb dysmetria) results in patients becoming wheelchair-bound within 5-20 years after 
disease onset (Aicardi et al., 1988, Barbot et al., 2001). AOA1 patients can also display 
a range of visual control defects, including and impaired ability to perform both 
horizontal and vertical eye movements (Aicardi et al., 1988, Le Page et al., 2003). They 
take longer to focus on an object and have difficulty coordinating the movements of the 
eyes and head to track a moving object (Le Ber, Brice, and Dürr 2006). Some patients 
also display dysarthria and/or masked facies (a reduced capactiy to display facial 
expression (Aicardi et al., 1988, Le Ber et al., 2006). Reports of the mental capacity of 
AOA1 patients have produced conflicting results: Le Ber et al. reported mental 
impairment (either retardation or dysexecutive  syndrome) in all patients examined, 
while Aicardi et al. reported that their patients had normal intelligence (Aicardi et al. 
1988). Atrophy of the cerebellum is obvious upon MRI imaging, even early in the 
course of the disease (Le Ber, Brice, and Dürr 2006).  
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Although hypoalbuminemia and hypercholesterolemia are characteristic biochemical 
markers of AOA1, they only become obvious after ~ 20 years of age (Le Ber, Brice, and 
Dürr 2006). The observed hypercholesterolemia is corrected by infusion of albumin, 
while the hypoalbuminemia is not corrected by reducing serum cholesterol levels, 
indicating that the hypoalbuminemia causes hypercholesterolemia (Fukuhara 1995). The 
rate of degradation of serum albumin is normal (Le Ber et al., 2006, Tranchant et al., 
2003), suggesting that albumin synthesis in the liver is impaired.  Interestingly, although 
it shares many neurological symptoms with other DNA repair defective disorders, such 
as ataxia-telangiectasia, it lacks any of the other extraneurological features such as 
immunodeficiency or cancer predisposition.  
 
Cell lines derived from AOA1 patients have been reported to be hypersensitive to a 
range of DNA damaging agents that generate single-strand breaks such as camptothecin, 
hydrogen peroxide, dl-buthionine-(S,R)-sulfoximine (BSO) (Clements et al., 2004, 
Gueven et al., 2004), and aprataxin has shown SSB end-processing function in vitro 
(Ahel et al. 2006). Data relating to the sensitivity of AOA1 patient cells and cultured 
APTX
-/-
 cells have been somewhat contradictory and one main aim of this thesis is to 
clarify these points.  
 
1.5.3  Aprataxin 
 
APTX is widely expressed in most tissues and across the nervous system. In situ 
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hybridization analysis of mouse brains reveals that APTX mRNA is expressed at high 
levels in Purkinje cells and cerebellar granular cells (Brenner 2002). In 2006, aprataxin 
was shown to demonstrate SSB end-processing function in vitro - in which a 5'AMP 
modification is deadenylated and the correct, ligatable 5'P terminus is restored (Figure 
1.14) (Ahel et al. 2006). 
 
The efficiency of deadenylation by aprataxin is equivalent at double-strand breaks and 
single-strand breaks but binds double stranded DNA with much higher affinity than 
single stranded DNA (Rass, Ahel, and West 2007a). Further to its SSB end-processing 
function, and through its interaction with various repair proteins, such as XRCC1, 
XRCC4 and MDC1, aprataxin is believed to have wider roles in the DNA damage 
response, although little is presently known about the function of these interactions.  
 
The forkhead associated (FHA) domain at the N-terminus of aprataxin is homologous to 
that of PNKP, and mediates interactions with CK2-phosphorylated XRCC1 in the 
formation of a single strand break repair (SSBR) complex (Clements 2004), following 
DNA damage (Gueven et al. 2004). Both PNKP and aprataxin are also sequestered to a 
double strand break repair (DSBR) complex through FHA domain-mediated interaction 
with CK2-phosphorylated XRCC4 (Clements et al. 2004). 
 
XRCC1, is a molecular scaffold protein that plays a central role in the recruitment of 
PARP-1, PNK, DNA polymerase β, and DNA ligase III to a SSBR complex, and there is 
evidence that these proteins may work synergistically in the DNA damage response 
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(Harris et al. 2009) (Figure 1.5). Recently, aprataxin was shown to interact with MDC1 
at sites of DNA damage (Figure 1.11). MDC1 is required for efficient phosphorylation 
of H2AX, for recruitment and retention of ATM and MRN at DNA breaks and for the 
recruitment of the ubiquitin ligase RNF8 to ubiquitinate H2AX at sites of damage 
(Becherel et al. 2010). 
 
Since the seminal paper by Ahel et al in 2006 identified the DNA repair function of 
aprataxin – resolution of abortive ligation intermediates – evidence has been building of 
further reaching roles for aprataxin in DNA repair, ranging from other direct repair 
functions (3' phosphatase activity and phosphoglycolate removal (Takahashi et al. 2007) 
to involvement in repair protein complexes (Becherel et al., 2010, Clements et al., 2004, 
Harris et al., 2009, Rass et al., 2007) to modulating the transcription of key repair 
proteins (Harris et al. 2009)). This thesis aims to extend understanding of aprataxin 
function, using in vitro DNA repair assays, cell-based assays and tissues from animal 
models. 
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Chapter Two 
 
Materials and Methods 
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2.1   Generation of mutant mice 
 
The Aptx
-/-
 mice were generated as described previously in C57/6J/129 background 
(Ahel et al. 2006; El-Khamisy et al. 2009). To generate the Aptx/SOD1 double mutants, 
Aptx
+/-
 females were crossed with male SOD1
G93A
 transgenic mice kindly supplied by 
the Jackson laboratory (Gurney et al. 1994) (female SOD1
G93A
 mice are infertile 
expressing human SOD1
G93A
), for two generations . This breeding plan was used to 
generate Aptx
+/+
, Aptx
-/-
, Aptx
+/+
SOD1
G93A
 and Aptx
-/-
SOD1
G93A
 mice (and embryos for 
generating MEFs). See Table 2.i and 2.ii for details on animals and tissues used in the 
study. 
 
 
2.2   Isolation, genotyping and maintenance of MEFs 
 
All cells used in the study were MEFs isolated from embryos on embryonic day 13 by 
separation from head and limbs and quick homogenisation by pipette in trypsin, and 
then cultured in complete medium (DMEM supplemented with 15% FCS, 100 units/ml 
penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine) in 3% O2 and 5% CO2, at 37
o
C. 
Genotyping of adult mice was done using tail biopsies and genotyping of embryos was 
done using the embryo heads. Genotypes of MEFs were further confirmed by repeating 
the PCR on cellular lysate. Tissues were digested in lysis buffer: 20 mM tris-
hydrochloric acid (Tris- HCl) (pH 7.5), 10 mM EDTA, 1 mM EGTA, 100 mM NaCl, 
1% Triton X-100, containing proteinase K (10 mg/ml, Invitrogen), 2 µl in 200 µl lysis 
buffer, 55
o
C overnight. The soluble DNA produced was diluted 1:50 and used as a 
template in PCR reactions containing three primers for the aprataxin gene, as described 
previously (Ahel et al. 2006). PCR products were run on a 1% agarose DNA gel. 
Genotyping tissues for SOD-1 was performed by digestion of biopsies (as above) and 
amplification by PCR using the method of the Jackson laboratory, with a set of primers 
to amplify both the endogenous SOD-1, and the mutant human SOD-1. PCR products 
were run on a 1% agarose DNA gel (0.0001% EtBr) and visualised with UV. Details of 
the primers used may be found in Table 2.iii. 
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2.3   Preparation of cell-free protein extracts 
 
Approximately 5 x 10
5
 cells were harvested by centrifugation at 1,500 rpm and washed 
three times in PBS. Cell pellets were lysed by incubation with 0.2 ml cell lysis buffer on 
ice and cell free extracts were prepared by centrifuging at 13,000 rpm for 20 min at 4°C. 
The supernatant was retained and the protein concentration quantified by the Lowry 
method using the DC Protein Assay (BioRad) with BSA used as a protein standard. 
 
 
2.4   SDS - Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
SDS-PAGE gels consisting of 10% resolving gel (10 ml final volume: 4 ml ddH2O, 
3.3 ml 30% acrylamide/bisacrylamide (37.5:1) mix (Flowgen), 2.5 ml 1.5 M Tris pH 
8.8, 0.1 ml 10% SDS, 0.1 ml 10% APS, 4 μl TEMED) and 5% stacking gel (4 ml final 
volume: 2.7 ml ddH2O, 0.67 ml 30% acrylamide/bisacrylamide (37.5:1) (Flowgen) 
0.5 ml, 0.5 ml 1M Tris pH6.7, 40 μl 10% SDS, 40 μl 10% APS, 4 μl TEMED), were 
prepared according to Sambrook and Russell (Sambrook and Russell, 2001). Protein 
samples (purified recombinant protein, bacterial and mammalian cell extract) were 
denatured by incubation in SDS loading buffer (50 mM Tris pH8.0, 2% w/v SDS, 10% 
w/v glycerol, 0.1% w/v bromophenol blue 200 mM DTT) at 94°C for 5 min. The 
denatured samples were briefly centrifuged at full speed and aliquots were separated on 
SDS-PAGE using Precision Plus Protein Prestained Dual Colour Standards (BioRad) as 
markers. Electrophoresis was carried out using Mini Protean 3 apparatus (BioRad) in 1x 
running buffer (25 mM Tris, 250 mM glycine, 0.01 % w/v SDS) at 150 V for 60 min. 
Total protein was visualised by staining in Coomassie brilliant blue solution (0.25% w/v 
Coomassie brilliant blue G-250 (BioRad, 50% v/v methanol, 10% v/v acetic acid) for 30 
min and destaining (10% v/v methanol, 10% v/v acetic acid) for 30 min and dried. 
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2.5   Immunoblotting of proteins 
 
Cell free extracts were aliquoted and stored at -80°C. Samples were run on a 12.5% 
SDS-PAGE gel. Proteins were transferred to a Hybond C extra nitrocellulose membrane 
at 25 V for 2 h (wet transfer method). Following transfer, the membrane was blocked 
(5% milk in PBS for 1 h at RT), and incubated overnight at 4
o
C with primary antibody: 
Aprataxin (Anti-APTX rabbit polyclonal, Taylor lab, 1:1000, 5% milk), or SOD1 (Anti-
SOD1 rabbit polyclonal, Santa Cruz Biotechnology, 1:2000, 5% milk). β-actin was used 
as a control (Anti-β-actin mouse monoclonal, Sigma, 1:2000, 5% milk). The membrane 
was then washed in Tris-Buffered Saline/Tween 20 (50 mM Tris, 150 mM NaCl, 0.05% 
Tween, adjust pH with HCl to pH7.6) and then incubated at room temperature for one 
hour in goat anti-rabbit HRP-conjugated secondary antibody (Dako, 1:4000) or anti-
mouse HRP-conjugated secondary antibody (Dako, 1:5000) in 1 x TBST. Membranes 
were washed again and incubated in enhanced chemiluminescence (ECL) western 
blotting detection reagent (GE Healthcare) for 1 minute and developed on 
autoradiography blue sensitive film (GRI) using a Xograph Compact 4 automatic X-ray 
film processor.   
 
 
2.6   Overexpression of recombinant aprataxin in E.Coli 
 
The pB352-hAPTX bacterial expression vector (Clements et al., 2004) was transformed 
into chemically competent BL21 (DE3) E.coli cells: 0.2 – 2 μg plasmid DNA was 
incubated with 50 μl of chemically competent BL21 (DE3) cells on ice for 30 min 
before heat shocking at 42°C for 45 sec, and then cooling on ice for 5 min. 1 ml of LB 
was added, then the transformation mixture was incubated at 37°C for 1 h while shaking 
at 220 rpm. The transformation mixture was plated onto LB agar plates containing 
50 μg/ml ampicillin and incubated overnight at 37°C. Single colonies were picked and 
used to inoculate 10 ml starter culture consisting of LB containing 50 μg/ml of the 
appropriate antibiotic and the culture was incubated overnight at 37°C, shaking at 
220 rpm. 
 
 
80 
 
The starter culture was centrifuged at 4,800 rpm for 20 min, resuspended in fresh LB 
media and diluted into a large scale 500 ml culture and incubated at 30°C to a final 
OD600 = 0.01. The large scale aprataxin culture reached OD600 = 0.01 after 3 hours and 
was used for further purification steps. The culture was incubated at 30°C until OD600 = 
0.6 and a 1 ml pre-induction sample was taken for analysis, 0.5ml of 1M IPTG was 
added to make a final concentration 1mM and the culture was incubated at 30°C until 
OD600 = 1.2. A 1 ml post induction sample was taken for analysis and the rest of the 
culture was harvested by centrifugation at 5,000 rpm for 20 min. The pellet was washed 
once in PBS and stored at -20°C. Aliquots of the 1 ml pre- and post-induction samples 
were analysed by SDS-PAGE. 
 
 
2.7   Preparation of clarified cell extract from E. Coli 
 
Bacterial cell pellets containing overexpressed recombinant aprataxin were resuspended 
in 20ml sonication buffer (25 mM Tris-HCl (pH7.0), 0.5 M NaCl, 10% glycerol, 1 mM 
DTT, 1 mM imidazole (pH8.0) and 1 mM PMSF). Crude cell extract was prepared by 
sonicating the resuspended cell pellet at 30% power for 10 X 30 sec bursts, each 
followed by a 30 sec cooling period. The soluble was separated from the insoluble 
material by spinning at 14,000 rpm for 20 min at 4°C. The supernatant was retained, 
snap frozen in liquid nitrogen and stored at -80°C. 100 μl samples of the soluble and 
insoluble material were retained for anaylsis by SDS-PAGE. 
 
 
2.8 Purification of His-tagged aprataxin by immobilized affinity 
chromatography 
 
Human recombinant His-tagged APTX was overexpressed in BL21 (DE3) E.coli cells 
as previously described. The first purification step was immobilised metal affinity 
chromatography (IMAC) on Ni-NTA agarose beads (first described in Porath et 
al.1975). In IMAC, metal ions (Ni
2+
) are bound to a metal chelating group (NTA) 
immobilised on agarose beads. The Ni
2+
 ions form interactions with imidazole side-
chains present within histidine residues, retaining any histidine containing proteins on 
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the beads. To take advantage of this proteins are fused to tags consisting of six or ten 
histidine residues, allowing the recombinant protein to bind to the Ni
2+
 on the column 
with high affinity. Proteins are eluted from the beads with a buffer containing an excess 
of free imidazole, which competes with the histidine side chains for interaction with the 
column. A Ni-agarose column with a 5.0 ml bed volume was prepared by loading 1 ml 
Ni-NTA Agarose resin (Qiagen) onto a Bio-Rad PolyPrep column and washing with 10 
column volumes of sonication buffer (25 mM Tris-HCl, 0.5 M NaCl, 10% glycerol, 
1 mM DTT, 1 mM imidazole (pH8.0)). 20 ml clarified E.coli extract containing His-
tagged recombinant protein was loaded onto the Ni-NTA agarose column at 4°C. All 
subsequent steps were also carried out at 4°C. The column was washed three separate 
times with 10 column volumes of sonication buffer containing 20 mM, 40 mM and 
80 mM imidazole respectively. His-tagged protein was then eluted with 5 column 
volumes of sonication buffer containing 250 mM imidazole and 0.5 ml elution fractions 
were collected. Aliquots of the column load, flow through, washes and elution fractions 
were analysed by SDS-PAGE. Samples were snap frozen and stored at -80
o
C. 
 
 
2.9 Purification of recombinant aprataxin by cation exchange 
chromatography 
 
IMAC elution fractions containing His-APTX were subsequently purified by cation 
exchange chromatography using a 1.6 ml POROS column on a BioCAD ® Sprint 
Perfusion Chromatography System (Applied Biosystems, United Kingdom). The 
column was washed with 20 column volumes of ice cold high salt buffer (25 mM Tris-
HCl, 1 M NaCl, 10% glycerol, 1 mM DTT) and then 20 column volumes of ice cold 
low salt buffer (25 mM Tris-HCl, 0.1 M NaCl, 10% glycerol, 1 mM DTT). Prior to 
washing, the high and low salt buffers were filtered through a 0.22 μm filter unit. pH 
strongly affects the charge characteristics of a protein and the affinity of the target 
protein for the column. The isoelectric point (pI) of a protein describes the pH at which 
a molecule has a net charge of zero. Accordingly, the purification of proteins must be 
carried out at pH specific to the pI of that protein to optimise the yield. Accordingly, 
recombinant aprataxin was purified using buffers of pH 8 (Table 2.iv). Buffers were 
made as described above and pH-adjusted with NaOH. All buffers and protein solutions 
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were kept on ice. Peak elution fractions from IMAC were pooled, loaded onto the cation 
exchange column and washed with 10 column volumes low salt buffer. His-APTX was 
eluted with a salt gradient from 0.1 M NaCl to 1 M NaCl over 15 column volumes. 1 ml 
elution fractions were collected. Aliquots of the column load, flow through and elution 
fractions were analysed by 10% SDS PAGE and peak fractions were dialysed into 
storage buffer (25 mM Tris-HCl, 150 mM NaCl, 10% glycerol, 1 mM DTT) using a D-
Tube Dialyzer (Novagen). The protein concentration of the final dialysed fractions was 
quantified by the Lowry method using the DC Protein Assay (BioRad) with BSA used 
as a protein standard. The dialysed fractions were aliquoted, snap frozen in liquid 
nitrogen, and stored at -80°C. 
 
 
2.10   Urea Polyacrylamide Gel Electrophoresis (Urea PAGE) 
 
Urea polyacrylamide gels were prepared using the SequaFLOWGel Sequencing Kit 
(Flowgen Bioscience) using a 21 cm x 40 cm Sequi-Gen GT Sequencing Cell (Bio-
Rad). Radiolabelled DNA was denatured by heating to 90°C in formamide loading 
buffer (30% formamide, 0.04% w/v bromophenol blue) and was separated on 15% urea 
polyacrylamide gels (50ml total volume: 30 ml SequaGel Concentrate, 15 ml SequaGel 
Diluent, 5 ml SequaGel Buffer, 40 μl TEMED. Prior to loading of the DNA samples, 
the polyacrylamide gel was pre-run by carrying out electrophoresis at 45 W for 45 min. 
Denatured DNA samples were then loaded and electrophoresis was carried out in 1 x 
TBE (90 mM tris, 90 mM boric acid, 2 mM EDTA) at 45 W for 90 – 180 min. After 
electrophoresis the polyacrylamide gel was incubated in 10% acetic acid 10% methanol 
for at least 20 min, dried and exposed to a Phosphor Screen (GE Healthcare). 
Radiolabelled DNA was detected by phosphorimaging using a Storm™ phosphoimager 
(GE Healthcare) and visualised by ImageQuant TL software (GE Healthcare). 
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2.11   Native Polyacrylamide Gel Electrophoresis (Native PAGE) 
 
15% native polyacrylamide gels were prepared using 40% acrylamide/bis-acrylamide 
(19:1) solution and 1 x TBE. DNA samples were loaded onto the native acrylamide gel 
in type II loading buffer (0.04% w/v bromophenol blue, 0.04% w/v xylene cyanol FF, 
2.5% w/v ficoll (Type 400 from Pharmacia)) in distilled water. Electrophoresis was 
carried out using Mini Protean II apparatus (Bio-Rad) in 1 x TBE at 80 V for 2 h. After 
electrophoresis the polyacrylamide gels were incubated in 10% acetic acid 10% 
methanol, dried and exposed to Phosphor Screens (GE Healthcare). Radiolabelled DNA 
was detected by phosphorimaging using a Storm™ phosphoimager (GE Healthcare) and 
visualised by ImageQuant TL software (GE Healthcare). 
 
 
2.12   Preparation of radiolabelled oligonucleotides 
 
To prepare a radiolabelled oligomer for preparation of substrates to visualise DNA 
damage repair by cell extract and recombinant protein, 1 nmole of appropriate oligo was 
incubated with 2 µl T4 PNK (Roche Applied Science) and 2µl (5mCi/ml) [γ-32P]-ATP 
in 1 x PNK buffer to a total volume of 40 µl and incubated at 37
o
C for 1 h and then at 
70°C for 10 min to de-activate the enzyme. Unincorporated radionucleotides were then 
removed by applying the reaction to an illustra MicroSpin™ G-25 Columns (GE 
Healthcare) and centrifuging according to manufacturer’s specifications. 
 
To prepare a SSB substrate in which repair of the 5’ termini could be visualised, the 
oligomer upstream of the break (a 25mer or a 14mer in all experiments contained within 
this thesis) was 5’-radiolabelled. 
 
To prepare a SSB substrate in which repair of the 3’ termini could be visualised, the 
oligomer downstream of the break (an 18mer in all experiments contained within this 
thesis) was 5’-radiolabelled. To radiolabel an 18mer harbouring a 3’ phosphate 
modification, T4 PNK 3’ phosphatase free mutant (Roche) was used to prevent 
processing of the 3’ termini. 
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The success of the radiolabelling was determined by analysing a sample of the reaction 
products by 15% urea PAGE. The radiolabelled oligonucleotides were annealed to a 
two-fold molar excess of appropriate unlabelled oligonucleotides by incubating 95°C 
for 5 min and then at RT for 30 min each before placing on ice. A control sample 
lacking either the oligomer upstream or downstream of the break was annealed in 
parallel to use as a size reference. The annealed products were fractionated by 15% 
native PAGE to check annealing efficiency. 
 
All oligonucleotides used are detailed in Table 2.v and were obtained from Eurofins 
MWG Operon. 
 
 
2.13   Preparation of model DNA single strand break substrates 
 
Annealing reaction: Radiolabelled oligomer was annealed to a two-fold molar excess 
of unlabelled counterparts by incubating together at 95
o
C for 5 min and then at RT for 
30 min, then on ice for 10min. 
 
To prepare double stranded oligonucleotide duplex harbouring a SSB but no missing 
nucleotides (referred to henceforth as a nick substrate) in which repair of the 5’ termini 
could be visualised, the radiolabelled 25mer was annealed with an 18mer and 
complimentary 43mer oligonucleotide backbone.  
 
Model abortive ligation intermediates (nick substrates with 5’-AMP modification at the 
break, were prepared by adenylating a nick substrate using a T4 DNA Ligase. 7.5 μM of 
the nick substrate was incubated with 1 U of T4 DNA Ligase (Roche) at 30°C for 1 h in 
25 mM Tris-HCl (pH7.5), 130 mM KCl, 1 mM DTT, 10 mM MgCl2, and 1 mM ATP. 
A mock adenylated control lacking T4 DNA ligase was prepared by incubated 7.5 μM 
of the oxidative SSB with ligase storage buffer (20  mM Tris-HCl (pH 7), 60 mM KCl, 
1 mM EDTA, 5 mM DTT, 50% glycerol (v/v)). The adenylation reaction is not 
expected to run to completion and the reaction product will contain some unadenylated 
32
P-25mer, necessitating purification of the AMP-32P-25mer by denaturing gel 
extraction using the Crush and Soak method.  
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Crush and Soak method: The reaction products were fractionated by 15% urea PAGE 
and the position of the adenylated and mock adenylated 25mer oligonucleotides was 
determined by autoradiography using blue sensitive film. The AMP-
32
P-25mer and 
32
P-
25mer were excised from the gel. The DNA was eluted from the acrylamide by crushing 
the gel slice and incubating overnight at RT in 2 x volume Crush and Soak buffer 
(300 mM sodium acetate, 1 mM EDTA (pH8.0)). The resulting slurry was centrifuged 
at high speed and the supernatant retained. 1μl of Pellet Paint® NF Co-precipitant 
(Merck Biosciences) was added to the supernatant followed by 2 x volume of ice cold 
absolute ethanol. The solution was incubated at -80°C overnight and the DNA pelleted 
by centrifugation at 14,000 rpm for 20 min at 4°C. The pellet was washed twice with ice 
cold 70% ethanol, air dried and the purified DNA resuspended in 30 μl Buffer EB 
(Qiagen). 
 
Image-Quant software was used to determine the concentration of gel-extracted 
adenylated 25mer by comparing the signal produced of a known volume on a 15% urea 
PAGE gel to the signal produced by the same volume of pre-extraction 
32
P-labelled 
25mer of known concentration. Finally the adenylated 25mer was annealed to the 18mer 
and 43mer oligonucleotide backbone in a 1:2:2 ratio. 
 
The double stranded oligonucleotide duplex substrate harbouring a three nucleotide gap 
(referred to henceforth as gap substrates) in which gap-filling from the 3’terminus may 
be visualised, was prepared by annealing 5’-radiolabelled 18mer with 14mer and 
complimentary 36mer oligonucleotide backbone.  
 
Fully annealed duplexes were purified by fractionation of the annealing reaction 
products by 15% native PAGE and gel extraction using the crush and soak method as 
described previously, and quantified by comparison of signal produced on a native gel 
to that produced by oligo of known concentration, as described previously.  
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2.14   In vitro repair of adenylated nick substrates by cell-free protein 
extracts 
 
For reactions involving cell-free protein extracts, 25 nmol of adenylated SSB substrate 
was incubated with the indicated concentrations of protein extract for 60 min at 30°C in 
1 x reaction buffer (660 mM Tris- HCl, 50 mM MgCl2, 50 mM DTT, pH 7.5 at 
20
o
C),10 μM deoxynucleoside triphosphates (dNTPs), 1 mM ATP). 1000 x fold molar 
excess of competitor oligonucleotide (Table 2.v) was added to the reactions to suppress 
non-specific nuclease activity. Reactions were stopped by addition of 1/3 volume of 
formamide gel loading buffer (90% formamide, 0.12% w/v bromophenol blue) and 
denaturing by incubation at 90°C for 5 min. Reaction products were separated by 15% 
urea PAGE gels and visualised by phosphorimaging as described previously. Image-
Quant software was used to quantify spread of oligonucleotide product sizes by 
quantifying the signal of each product as a proportion of the sum of all products. 
 
 
2.15   In vitro repair of gap substrates by cell-free protein extracts 
 
For reactions involving cell-free protein extracts, 25 nmol of gap substrate was 
incubated with cell-free protein extract for 30 min unless otherwise stated at 37°C in 1 x 
reaction buffer (660 mM Tris- HCl, 50 mM MgCl2, 50 mM DTT, pH 7.5 at 
20
o
C),10 μM deoxynucleoside triphosphates (dNTPs), 1 mM ATP. 1000-fold molar 
excess of competitor oligonucleotide (Table 2.v) was added to the reactions to suppress 
non-specific nuclease activity. Reactions were stopped by addition of 1/3 volume of 
formamide ‘stop buffer’ (90% formamide, 0.12% w/v bromophenol blue, 10% glycerol) 
and denaturing by incubation at 90°C for 5 min. Reaction products were separated by 
15% urea PAGE gels and visualised by phosphorimaging as described previously.  
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2.16   In vitro repair of gap substrates by recombinant proteins 
 
Recombinant aprataxin was prepared as previously described. Recombinant Pol β, PNK 
and LigIIIα were kind gift from John Reynolds and were prepared as described in 
(Reynolds 2011). For in vitro repair reactions involving recombinant proteins, 100 nmol 
of gap substrate was incubated with the indicated concentrations of recombinant 
proteins for 30 min at 37°C unless otherwise stated in 1 x reaction buffer (660 mM Tris- 
HCl), 50 mM MgCl2, 50 mM DTT, pH 7.5 at 20
o
C), 10 μM dNTPs, 1mM ATP. 
Reactions were stopped by addition of 1/3 volume of formamide gel loading buffer 
(90% formamide, 0.12% w/v bromophenol blue) and denaturing by incubation at 90°C 
for 5 min. Reaction products were separated by 15% urea PAGE gels and visualised by 
phosphorimaging as described previously. 
 
 
2.17   Cell growth and survival assays 
 
Primary MEFs were used at passage 4-6 for survival assays. 100-600 cells per ml (the 
higher the dose of damaging agent, the higher the number of cells plated to produce a 
countable number of survival colonies according to test experiments) were grown in 
10cm
2
 plates (triplicates) and then treated with the appropriate DNA damaging agent: 
X-rays 250 kV at 12 mA, dose rate 0.5 Gy/min) using the AGO 320/250 X-ray cabinet, 
or H2O2 in PBS at the indicated doses, for 10min in the dark. Cells treated with X- rays 
were returned immediately to the incubator, and cells treated with H2O2 were washed 
three times in PBS and then returned to the incubator. In each experiment, all cells were 
allowed to grow for the same amount of time, between 5 and 7 days, until colonies had 
formed. Media was removed and cells were fixed with 80% ethanol for two minutes, 
then ethanol was removed. A minute later, enough 1% methylene blue stain was added 
to cover the bottom of the plate, and left for 30-40 mins. Stain was removed and plates 
left upside down to dry before colonies were counted. 
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The surviving fraction of cells of each genotype at each dose was calculated according 
to the number of colonies formed and the plating efficiency, using the equations:  
 
Plating Efficiency = colonies observed/number of cells plated  
 
Surviving Fraction = colonies observed/cells seeded x plating efficiency  
 
The average surviving fraction across triplicates was calculated and the logarithm of the 
average across all experiments (three X-ray experiments and four H2O2 experiments) 
was plotted against dose. Appropriate statistical tests for the clonogenic survival assays 
performed (two-tailed Student’s T-tests) were performed to calculate the standard error 
of the mean, using the equation: 
 
Results were replicated in two separate MEF lines and all assays were performed at 
early passage number – between passage 1 and 5.   
 
 
2.18   Senescence assays 
 
The senescence of primary MEFs was assayed at alternate passages up to passage 10, 
using the Senescence β-Galactosidase Staining Kit (Cell Signalling Technology), which 
exploits pH-dependent β-Galactosidase activity as a readout for senescence. MEFs were 
fixed with 80% ethanol for 10 min, then stained with X-Gal solution (20 mg/ml) and 
incubated at 37
o
C overnight (or as long as necessary to produce comparable staining 
between samples – between 24 and 72 h). Cells were observed under a microscope (200 
x total magnification) for development of blue stain. From each population, three 
representative samples of 100 cells each were counted to find the average percentage of 
cells stained blue (senescent). 
 
 
 
89 
 
2.19   RNA synthesis recovery assays 
 
MEFs were plated onto 3.5 cm dishes of each cell line at approximately 2 x 10
4
 cells in 
2 ml 15% FCS-medium containing 0.02 µCi/ml thymidine [2-
14
C] and incubated at 
37
o
C for 48 h (approximately 2 cycles) to label DNA . Medium was removed, cells 
washed with PBS, and incubated with either PBS or 50 µM H2O2 for 10 min at room 
temperature in the dark. Cells were washed three times in PBS, and then 1 ml 15% 
FCS-medium containing 5 µCi/ml 
3
H-uridine was applied and cells were incubated for 
15 mins. Medium was removed, and cells were washed three times in PBS. 0.25 ml 2% 
SDS was applied and the cells were scraped off the dish with a silicone rubber to collect 
DNA and RNA. Dishes were left tilted in rows. Strips of Grad 17 Whatman 
chromatography paper was marked into 16 x 1-inch labelled (in pencil) sections. 100 µl 
samples were pipetted onto paper strips, in duplicate. Strips were incubated with 5% 
trichloroacetic acid (TCA) for 5 mins followed by 2 x 5 min incubation with IMS. 
Finally, samples were left to dry thoroughly and radioactivity was quantified using the 
Beckman Coulter LS6500 Multi-Purpose Scintillation Counter. Results were plotted as 
RNA synthesis (% of unirradiated) against dose. 
 
2.20   Alkaline single-cell agarose gel electrophoresis (comet assay) 
 
Approximately 2 x 10
5
 MEFs at passage 5 were plated in 3.5 cm culture dishes in 
complete media and incubated for 16 h at 37
o
C prior to mock-treatment (control) or 
treatment. For H2O2 treatment, cells were incubated with 90 µM H2O2 in PBS on ice for 
10 mins. Control cells were incubated with PBS on ice for 10mins. For exposure with 
20 Gy γ-rays, 4 x 105 cells/ml were irradiated in suspension in complete medium using 
a 
137
Cs gamma source (dose rate 7.5 Gy/min), controls were incubated at the same 
temperature for the same amount of time, but unirradiated. After treatment with H2O2 or 
γ-rays cells were washed in ice-cold PBS and incubated for the desired repair periods. 
Adherent cells were trypsinised and harvested in ice-cold PBS (1 ml/3.5 cm plate) and 
0.2ml of the cell suspension analysed by alkaline comet assay as described previously 
(Chiang, Carroll, & El-Khamisy, 2010). Briefly, cells were immobilized in agarose on 
slides, lysed and eletrophoresed. DNA was neutralised, stained with SYBR green 
(1:10000 dilution) and visualised by fluorescent microscopy (Nikon Eclipse E400) at 20 
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x magnification. Comet tail moment for 100 cells per sample was determined using 
Comet Assay IV software (Perceptive Instruments). The average tail moment and 
scatter graphs of tail moments were plotted for each repair time point. Each sample was 
tested in triplicate in each experiment. The average surviving fraction from five 
independent experiments was plotted (+/- standard error of the mean - SEM). 
Statistically significant differences were determined using SPSS software: ANOVA 
(two-factor with replication). 
 
2.21   Telomere length assays 
 
This assay (described in Chang and Harley, 1995, and Landsorp et al., 1996) was 
performed for the most part as described in the TeloTAGGG Telomere Length Assay® 
specification manual (Roche cat. # 2209136), with a few modifications. 
 
DNA digestion and separation 
 Genomic DNA was digested by a Hinf I/Rsa I enzyme mixture – 20 U/µl of each, and 
incubated for 2 h at 37
o
C. The reaction was stopped by adding gel electrophoresis buffer 
and quick-spinning of the reaction vials. Separation of digested DNA was done by 
agarose gel electrophoresis following standard protocols on a 0.8% agarose gel in 1 x 
TAE buffer (0.04M Tris-acetate, 0.001 M EDTA, pH 8.0). 1-2 µg of each digested 
DNA sample is loaded into each lane, with one lane on either side of the gel set aside 
for a molecular weight marker. The gel was run at 5 V/cm in 1 x TAE buffer for 3-4 h. 
Southern transfer 
Southern transfer was performed by capillary transfer using 1 x SSC transfer buffer (20 
x SSC: 3M NaCl, 0.3M Sodium Citrate, pH7.0) to a positively charged nylon 
membrane. After the transfer, the DNA was fixed on the wet blotting membrane by UV-
crosslinking (120 mJ). The blotting membrane was washed twice with 2 x SSC buffer 
for 10 min. 
Prehybridization 
The blot was incubated in pre-warmed digoxigenin-labeled probe (DIG) at 42
o
C with 
gentle agitation. 
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Hybridization 
The hybridization and chemiluminescence detection steps were performed according to 
the TeloTAGGG telomere length ass protocol (Roche cat. # 2209136). 1 µl telomere 
probe (digoxigenin-labelled telomere specific hybridization probe, Roche cat. # 
2209136) was added per 5ml prewarmed DIG solution and the membrane was 
incubated in the new solution for 3 h at 42
o
C with gentle agitation. The membrane was 
washed twice with stringent wash buffer I (2 x SSC, 0.1% SDS) at RT with gentle 
agitation, then washed twice with stringent wash buffer II (0.2 x SSC, 0.2% SDS) at 
50
o
C (each wash for 15-20 min with gentle agitation). 
Detection of Telomeric DNA  
The membrane was washed in at least 100 ml 1 x washing buffer (1 x maleic acid buffer 
(100mM maleic acid, 150mM NaCl, 0.1% Tween-20), 3-5% Tween-20) for 1 – 5 min at 
RT with gentle agitation. The membrane was incubated in 100 ml 1 x blocking solution 
for 1 hr at RT with gentle agitation. Next the membrane was incubated in 50 ml Anti-
DIG-AP working solution (0.75 μg/μl, Fab fragments of polyclonal antibody from sheep, 
conjugated to alkaline phosphatase (AP), Roche, #2209136) for 30 min at RT with gentle 
agitation, washed twice, then incubated in 100 ml 1 x detection buffer (Roche, 
#2209136, undisclosed ingredients) for 2-5 min at RT with gentle agitation. The 
detection buffer was discarded and excess liquid removed from the membrane by 
placing the membrane, DNA side up, on a sheet of absorbent paper. The membrane 
must not dry out. The wet membrane was placed immediately, DNA side up, on a page 
of acetate and approx. 20 drops substrate solution (Roche, #2209136 formulation 
undisclosed but containing CDP-Star, a highly sensitive chemiliminescence substrate) were 
immediately applied to the membrane. Another piece of acetate was immediately placed 
on top and all bubbles squeezed out to ensure an even application. The membrane was 
incubated in substrate solution in the dark for 5 min at RT. Then excess substrate 
solution was squeezed out and the membrane and acetates were wrapped in cling-film 
and exposed to X-ray film for 20 min at RT. Signals produced by various cell samples 
were compared by eye. The positive control DNA supplied with the kit is purified 
genomic DNA from immortal cell lines. 
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2.22   Cell cycle analysis 
 
Cell cycle analysis experiments were performed using primary MEF cultures. 1 x 10
5 
- 1 
x 10
6
 cells were harvested, centrifuged and medium removed. Cells were resuspended in 
200 µl cold PBS and 700 µl ice cold ethanol was added drop by drop whilst vortexing to 
avoid clumping and left at -20
o
C for 2 h. 
 
Cells were washed twice with PBS and 500 µl of propidium iodide solution was added 
per sample (25 µl RnaseA  1 x, 25 µl propidium iodide (Sigma) 50 ug/ml, 450 µl PBS). 
Tubes were wrapped in foil and left at room temperature for 15 mins. Samples were 
analysed on FACSCanto which sorts cells according to nuclear material and cell size. 
The spread of cells were arranged into 'gates' and these were used as approximations of 
stages of the cell cycle. Results were plotted on bar charts for comparison. 
 
2.23   Quantitative Polymerase Chain Reaction (Q-PCR) 
 
For analysis of IGF-1 expression by qPCR, RNA was extracted from adult mouse liver 
(aged 3 months) using the RNeasy Plus Mini Kit (Qiagen), checked for DNA 
contamination by running a sample on a DNA gel, and then cDNA was generated using 
the Promega reverse transcription system, in which 2 µg RNA and 0.5 g oligo dT are 
incubated at 70
o
C for 5 min and then added to a master mix of M-MLV 5X Reaction 
Buffer (5 µl), 10 mM dNTPs (1.25 µl) Recombinant Rnasin®  Ribonuclease Inhibitor 
(25 units), and M-MLV Reverse Transcriptase (200 units), and incubated at 42
o
C for 1 
h. Then 1 µl RNase A (Promega) was added and the mixture was incubated at 37
o
C for 
30 mins. cDNA was purified with the QIAquick Spin PCR purification kit and 2.5 µl of 
the product used in Q-PCR reactions with Quantitect SYBR® Green PCR Master Mix 
(Qiagen), 100 nM each of the appropriate forward and reverse primers, (see Table 2.vi 
for primer details), and water to make solutions up to 25 µl. The reactions were run in a 
Stratagene MX4000 Q-PCR machine.  
 
All data sets were collected from three samples from at least two animals for each 
genotype. Each qRT-PCR reaction was carried out in triplicate with at least three 
reactions for each gene. For analysis the mean CT of the β-actin (control) triplicates 
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were calculated for each genotype and then subtracted from each genotype’s individual 
triplicate CT for the IGF-1 (gene of interest) to give a calibrated ΔCT. The mean ΔCT 
of the comparator genotype was then subtracted from the ΔCT of each genotype of 
interest’s gene of interest ΔCT to give a comparative ΔΔCT. To calculate a fold change, 
the ΔCT of the comparator’s IGF-1 triplicates was divided by the mean ΔCT of the 
comparator resulting in a mean value of 1. A fold change for the other genotypes was 
calculated by 2
-ΔΔCT
 for each triplicate. Fold change significance was analysed across 
the experiments using a Student’s T-Test. 
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Chapter 3 : Results (1) 
 
Aprataxin facilitates gap 
filling at single-stranded 
DNA breaks in vitro  
 
 
 
 
 
 
 
 
 
 
 
 
94 
 
3.1  Introduction 
 
Resolution of SSBs is a multi-step chemical process involving the formation of reaction 
intermediates. One such intermediate results from the adenylation of the 5’-terminus of 
the SSB, to form a 5'-adenosine monophosphate (5’AMP). The formation of a 5’AMP is 
catalysed by a ligase during the process of ligation - the final stage of repair. 
Adenylation of the 5'-phosphoryl (5’P) group activates it for formation of a 
phosphodiester bond by attack from a 3'hydroxyl (3’OH), covalently resealing the 
sugar-phosphate backbone of the DNA, restoring the duplex (Figure 1.14). 
 
If the 3’OH is not present, then the ligase may detach leaving the 5’AMP in a process 
called ‘abortive ligation’ (Figure 1.15). Aprataxin can remove the 5'AMP with high 
efficiency in vitro (Figure 1.13). Despite the existence of other mechanisms to remove 
this blocked terminus, mutations in aprataxin leading to loss of function (Date et al. 
2001; Moreira et al. 2001) or nuclear transport (Crimella et al. 2011) result in the 
neurodegenerative disease Ataxia Oculomotor Apraxia (AOA1), characterised by 
cerebellar atrophy (Date et al. 2004; Moreira et al. 2001). Thus far the reasons for acute 
dependency upon aprataxin in the cerebellum remain elusive. The neural tissues of the 
cerebellum are adept at short-patch SSBR (Reynolds, El-Khamisy, Katyal, et al. 2009; 
El-Khamisy et al. 2009) but the expression of proteins that have hitherto been associated 
with long-patch SSBR (such as the clamp PCNA and flap cleavage enzyme FEN1) is 
limited (Englander 2008). This chapter provides evidence that aprataxin promotes 3' 
extension to fill the gap at a single-strand break. Conversely, in the absence of 
aprataxin, 3' extension is attenuated.  
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3.1.2  Aims of this chapter 
 
Since the discovery that aprataxin cleaves 5’AMP in vitro, efforts have been focused on 
confirming this activity in cells, and correlating it with the pathogenesis of AOA1, the 
cerebellar ataxia resulting from a loss of aprataxin function. Aprataxin-deleted chicken 
DT40 cells, Aptx
-/-
 mouse fibroblasts, AOA1 human fibroblasts, and AOA1 
lymphoblastoid cells have all failed to demonstrate a measurable defect in global SSBR 
rates (Reynolds, El-Khamisy & Caldecott 2009). However, a global SSBR defect was 
observed in TDP
-/-
Aptx
-/-
 cortical astrocytes (El-Khamisy et al. 2009). 
 
Questions in mind while designing and undertaking the experiments discussed 
here were: 
 
 What is the relevant toxic lesion in the pathogenesis of AOA1? 
 
 What is the order of events during repair of a SSB? 
 
 Does the adenylation of a 5' terminus by a ligase take place before the 
filling of the gap? 
 
 If so would this have an effect on the gap-filling reaction? 
 
 Would an aprataxin-deleted cell lysate be able to repair single-strand 
breaks missing more than one base as efficiently as a wild-type 
counterpart?  
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3.2  Results 
 
Recombinant aprataxin was overexpressed in E. Coli (Figure 3.1 A) and purified by 
IMAC (Figure 3.1 B) and cation exchange chromatography. The eluted aliquot with the 
best yield/purity was selected and quantified by comparison to a BSA standard titration 
(Figure 3.1 C).  
 
To test the enzymatic activity of the lysates, DNA substrates were prepared to assess the 
activity of Tdp1: an 18mer with a radiolabel (
32
P) at the 5' terminus and either a 
phosphotyrosine or a phosphate at the 3' terminus (Figure 3.2 A). To test the enzymatic 
activity of the recombinant aprataxin and confirm the presence of aprataxin activity in 
Wt lysates, and the lack of aprataxin activity in Aptx
-/-
 lysates, two DNA substrates 
were prepared: a 25mer with a radiolabel (
32
P) within the phosphate group at the 5' 
terminus (25P), and a similar radiolabelled 25P, with an AMP group bound to the 
radioactive 5’ phosphorus (25A) (Figure 3.2 B).  
 
Wild-type and Aptx
-/-
 MEFs were isolated, genotyped and cultured, and cell-free lysates 
were prepared. Activity of Tdp1 in both lysates was confirmed by in vitro repair 
experiments in which both lysates demonstrated ability to cleave tyrosine from the 18Y 
DNA substrate (Figure 3.2 C). Absence of expression in the Aptx
-/-
 cells was confirmed 
by Western blot, with β-actin used as the control protein (Figure 3.2 D).  
  
In vitro repair experiments using the 25A DNA substrate confirmed the ability of 
recombinant aprataxin and Wt lysate to cleave 5’AMP. Similar concentrations of Aptx-/- 
lysate demonstrated no 5’adenylate cleavage activity (Figure 3.2 E). 
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In order to test the ability of the lysates to repair a single-strand break a "gap substrate" 
was prepared, in which  a 5' 
32
P radiolabelled 18mer, and a 14mer were annealed to a 
complementary 36mer in order to make a double stranded oligonucleotide duplex 
harbouring a SSB with a 3'OH and 3 nucleotide gap (Figure 3.3 A). The 3'OH group 
present is the substrate for a DNA polymerase, which can extend from the 3'OH to fill 
the gap (Figure 3.3 B). 
 
Reactions to test the activities of Wt and Aptx
-/-
 lysates on the gap substrate showed less 
extension by the Aptx
-/-
 lysate reaction than by the Wt lysate. As well as a reduction in 
the amount of fully repaired product, the size of products formed overall were smaller in 
the Aptx
-/-
 reaction (Figure 3.3 C). Two repeats of the reactions presented in Figure 3.3 
were carried out, using the same lysate aliquots, the same conditions and were run 
simultaneously (Figure 3.3 A and B). The relative abundance of each size of product 
formed was calculated using ImageQuant and the data were combined to quantify the 
variation in spread of product size and the variation between similar experiments 
(Figure 3.4 E).  
 
Next, repair reactions were set up containing either Wt, or Aptx
-/-
 lysate, and 
combinations of the recombinant proteins PNK, Pol β, ligase III α (Figure 3.5 A). The 
reaction time was 1.5 hrs and most of the reactions proceeded to 36mer (or even one 
nucleotide further in some cases). But the products of the reaction containing Aptx
-/-
 
lysate and no ligase (Figure 3.5 A, lane 6) were significantly smaller – i.e. the reaction 
had not continued as far as the other reactions. In the absence of the recombinant ligase, 
Wt lysate was able to complete repair to make the complete 36mer, but the Aptx
-/- 
lysate 
was not.  
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The results suggest that the lack of aprataxin activity in Aptx
-/-
 lysate result in a blocked 
5’ terminus that is unavailable for ligation, thereby forcing the polymerase activity 
(most likely Pol β as it is in excess in these reactions) to displacement synthesis which 
takes longer to extend to the full length of the oligonucleotide than simply filling the 
gap (non-displacement synthesis) and ligation. Quantifications of the products produced 
by reactions run in lanes 3 and 6 were plotted on a bar chart as an alternative illustration 
of the spread of product sizes produced (Figure 3.5 B). The difference between the size 
of products formed in reactions presented in lanes 3 and 6, that were similar other than 
containing either Wt, or Aptx
-/-
 lysate respectively, was so striking that further 
experiments involving recombinant Pol β and the cell lysates were carried out to 
investigate this observation. 
 
Further experiments with the cell lysates and titrations of Pol β in which reactions were 
run for 30 mins, in order to understand the early time-points of the reaction, showed that 
gap filling was impaired in the presence of Aptx
-/-
 lysate, relative to Wt lysate 
(Figure 3.6). The observed stalling at product size 21 appears to support the notion that 
repair of gap substrate by Wt lysate involves predominantly a non-displacement 
synthesis model. In this model, the gap is filled, and there is a brief pause while the 
ligation reaction takes place to complete repair. The Aptx
-/-
 lysate reaction shows DNA 
synthesis taking place at a slower rate than in the Wt reactions, at each concentration of 
Pol β used, and less evidence of stalling at product size 21 before proceeding to 
displacement synthesis (Figure 3.6). 
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The shorter reaction time of 30 mins was used for the rest of the in vitro experiments in 
order focus on the gap filling stage of the reaction. Further experiments showed that the 
difference in extension by Aptx
-/-
 lysate compared to Wt lysate changed with the 
amount of Pol β added (Figure 3.7). The greatest difference in 3’ extension observed 
was with Pol β at a concentration of 62nM. Presumably at higher concentrations of 
Pol β a displacement synthesis is favoured, regardless of the presence of aprataxin or 
not. Extension in the presence of Wt or Aptx
-/-
 lysate showed similar patterns of stalling 
but progressed at a slower rate in the reaction containing Aptx
-/-
 lysate, at all 
concentrations of Pol β (Figure 3.7). 
 
To test whether the effect was due to a direct interaction between aprataxin and 
polymerase, or dependent on components within the lysate, repair reactions were set up 
in which no lysate but a titration of recombinant Pol β and either recombinant aprataxin, 
or the same concentration of BSA, was present. Recombinant aprataxin was found to 
markedly increase the extension by recombinant Pol β, independent of lysate 
components (Figure 3.8), suggesting that the interaction is direct.  
 
 
3.3  Discussion 
 
The data presented in this chapter reveal that aprataxin promotes gap filling by the 
extension of a 3'OH at a DNA gap substrate. The repair of a "short-patch" 
(one-nucleotide gap) SSB in the absence of aprataxin was shown to be defective in vitro 
(Reynolds, El-Khamisy, Katyal, et al. 2009) when the 5' terminus is adenylated. In the 
experiments presented here, the DNA substrate has a three-nucleotide gap and the 5’ 
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terminus has not been pre-adenylated but the abortive action of a ligase at the 5’-P 
terminus could produce a 5’AMP. 
 
Aprataxin (which has DNA end processing activity) and polymerases (which can 
synthesize DNA to fill the gap at SSBs and anneal chromosome ends at double strand 
breaks) interact in the same multi-protein repair complexes (see Figure 3.9 and 3.10) 
(Caldecott 2001; Clements et al. 2004). These consist of X-ray cross-complementing 
proteins (XRCC1 and XRCC4, which serve as scaffolds to recruit and stabilize various 
repair proteins at the sites of SSBs and DSBs respectively). XRCC1-DNA Ligase III 
form the core of the protein complex coordinating SSB repair (SSBR) (Caldecott et al. 
1995; Caldecott et al. 1996) and XRCC4-LigIV form the core of the protein complex 
coordinating DSB repair (DSBR) (Grawunder et al. 1998).  
 
Such multi-protein complexes are responsible for detecting lesions, and coordinating 
correct repair. It is not currently known to what extent the complex is responsible for 
actively selecting the correct sequence of activities for the lesion but cross-talk between 
proteins in the complex is likely important, in order to spatially and temporally arrange 
the lesion-specific sequence of repair activities correctly. 
 
Reynolds et al. showed that in the absence of aprataxin, then short-patch repair of a 
5’AMP SSB is blocked in the presence of elevated levels of ATP due to low levels of 
non-adenylated ligase (Reynolds, El-Khamisy, Katyal, et al. 2009). The ATP 
concentrations used in the repair experiments presented here were moderate (1 mM) but 
may have been high enough to limit the availability of non-adenylated ligase available 
for ligation of a 5’AMP and 3’P.    
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The enhancement in recombinant Pol β activity in the presence of recombinant 
aprataxin alone - in the absence of cell lysate - (Figure 3.8) is surprising and intriguing, 
as it suggests that the activity enhancement occurs independent of any other SSBR 
machinery. 
 
Following an abortive ligation and in the absence of aprataxin to remove the resulting 
5'AMP, the attenuation of long-patch repair seems counter-productive. What would the 
effect be in cells? It may prevent the polymerase from unnecessarily proceeding to 
displace undamaged DNA (as is the case in the long-patch repair model), allowing more 
time for the 5’ terminus to be processed in order for ligation to take place.      
 
It may also reflect an in vitro – specific effect. One disadvantage of this in vitro repair 
assay is that it uses short stretches of linear DNA – quite unlike the DNA in cells. 
Furthermore, the process of lysis, snap freezing, thawing and the artificial conditions of 
the assay are unlikely to truly reflect the function of enzymes in situ. Therefore, whilst 
informative, it is difficult to extrapolate in vitro results to the situation at SSBs in cells 
or organisms, so the rest of the study into aprataxin function was carried out in cells and 
tissues from aged mice.  
 
To test the hypothesis arising from the data presented in this chapter, further 
experiments could be performed to address the following questions: 
 
 Do aprataxin and Pol β interact directly? 
 Could raising the level of Pol β present compensate for aprataxin deficiency in 
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post-mitotic tissue? 
 What would be the effect of losing both aprataxin and Pol β? 
 Questions regarding the order of events taking place at a gap substrate. For 
example:  
- At what stage does a ligase bind - and dissociate? 
- Can a 5’ moiety itself affect 3’ processing and gap filling steps? 
- Is co-ordination of SSBR influenced by intermediary proteins and if so, 
how?  
 
103 
 
 
 
Chapter 4 
 
Results (2) 
 
How does loss of aprataxin 
affect growth, survival, 
senescence, and DNA repair 
in cells? 
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4.1   Introduction 
 
Aprataxin has been shown to protect both nuclear and mitochondrial DNA against genotoxic stress, 
but so far the data on aprataxin function has fallen short of providing a comprehensive disease 
mechanism. Firstly, inaccessibility of the affected tissues and the inability to culture post-mitotic 
neurons (the cells that appear to be primarily affected in the disease) for use in functional assays 
have proved an obstacle. Whole animal models are apparently asymptomatic, and aprataxin-deleted 
mammalian cells in culture have so far revealed little or no defect in viability or DNA repair 
capacity (Becherel et al. 2006; Clements et al. 2004; Gueven et al. 2004; Harris et al. 2009; 
Mosesso et al. 2005). This probably suggests that only a small subset of breaks undergo abortive 
ligation to form the 5'AMP modification that is the substrate for aprataxin and that in most cellular 
circumstances, there are back-up repair pathways to compensate for a lack of aprataxin. 
 
In this study I aim to evaluate the role of aprataxin in response to oxidative DNA damage. In 
devising a new cellular model, the success of strategies used in previous studies were drawn upon, 
in which single-strand breaks are stabilised (i.e. repair is delayed) in order to increase the proportion 
of breaks that undergo abortive ligation to form 5'AMP, thereby providing a suitable cellular model 
to elucidate the relevant lesions and cellular effects. One such study used aprataxin deletion 
alongside TDP1 deletion to reveal a measurable DNA repair defect in mouse astrocytes, following 
treatment with the oxidising agent, H2O2. The same effect was observed to a lesser extent following 
treatment with the alkylating agent, MMS (El-Khamisy et al. 2009). Another study, this time in 
yeast, used a mutant RAD27 (homologous to FEN1 in humans) alongside loss of functional HNT3 
(homologous to the APTX protein in humans) in order to show a measurable survival defect 
following damage by H2O2 and - to a lesser extent the alkylating agent (Daley et al. 2010).  
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Data suggesting that unrepaired oxidative DNA damages are the most prominent relevant toxic 
lesion (El-Khamisy et al. 2009; Daley et al. 2010), led to the hypothesis that increasing the 
oxidative stress in a cell model would increase the cell's dependence on aprataxin and reveal a 
significant repair and survival defect in aprataxin-deleted cells. Here I used a mutant form of 
superoxide dismutase 1 (SOD1
G93A
), which induces oxidative base damage and single strand breaks 
in DNA, in line with an enhanced hydrogen peroxide production (Barbosa et al. 2010) and is widely 
used in models of neurotoxicity, especially in the study of amyotrophic lateral sclerosis (ALS) 
(Gurney et al. 1994; Howland et al. 2002). 
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4.2   Aims of this chapter 
 
The first aims of this chapter were to isolate and culture Aptx
-/-
 and Wt MEFs counterparts and to 
verify (or otherwise) the findings of others with respect to DNA repair assays.  The hypothesis 
arising from the literature on aprataxin function is that the primary critical lesions for which 
aprataxin is required for repair in the tissues of the cerebellum result from endogenous oxidative 
species. This hypothesis presents the testable prediction that if the oxidative load of a cell is raised, 
then the sensitivity of aprataxin-deleted cells may be increased to detectable levels. An important 
aim of this chapter was to test this prediction and assess the validity of raising the endogenous 
cellular oxidative load as a new model for examining aprataxin function in cells - more specifically, 
by use of transgenic expression of the human SOD1
G93A
 mutant. 
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4.3 Results 
 
Aprataxin-deleted primary murine fibroblasts exhibit slow population doubling, 
correlating with an accelerated senescence phenotype 
 
To investigate the effect of loss of aprataxin in cultured cells, Aptx
+/- 
mice were mated to generate 
Wt and Aptx
-/- 
MEFs were isolated and cultured for use in functional assays. Absence of aprataxin 
in Aptx
-/-
 cell lysate was confirmed by western blotting (Fig. 4.1A). To characterise Aptx
-/-
 MEFs 
we first monitored cellular growth of cells over a period of 50 days. Growth curves showed that 
Aptx
-/- 
MEF populations doubled slower than their Wt counterparts (Fig. 4.1B and Supp. Fig. S1 in 
Appendix II). I reasoned that the difference in growth rate may reflect the reduced ability of Aptx
-/-
 
cells to repair endogenous levels of DNA damage at optimal rate, as evidenced by my own previous 
findings that gap filling was impaired in Aptx
-/-
 lysates (Chapter 3 Results (1)) and those of others 
(Becherel et al. 2006; Clements et al. 2004; Gueven et al. 2004; Harris et al. 2009; Mosesso et al. 
2005; Reynolds et al. 2009). However survival assays showed no significant survival defect in 
Aptx
-/- 
cells following damage with X-rays or H2O2 (Fig 4.1 C,D), in agreement with previous 
reports (Clements et al. 2004)). The early plateau in the growth curve of Aptx
-/-
 cells relative to Wt 
cells (Figure 4.1B) suggested that Aptx
-/-
 cells may be starting to senesce early in response to 
persisting DNA damage. To test this, serum-arrested wild-type and Aptx
-/-
 cells were tested for 
levels of acidic β-galactosidase staining; a widely used hallmark of senescence (Dimri et al. 1995). 
These analyses revealed a marked passage-dependent acceleration of senescence in Aptx
-/-
 MEFs 
compared to wild-type counterparts (Fig. 4.2 A and B). Since the transcript profile of cells changes 
with ageing (Brink et al. 2009), this observation prompted an investigation into the cells’ capacity 
for transcription.   
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Transcription recovery following oxidative damage is delayed in aprataxin-deleted 
primary fibroblasts 
 
Reactive oxygen species are the predominant source of endogenous oxidative DNA breaks in cells 
(Lindahl 1993; De Bont 2004). Since unrepaired DNA breaks can block transcription we compared 
Wt and Aptx
-/-
 cells for their ability to resume transcription following oxidative DNA damage. 
Whilst incubation of cells with hydrogen peroxide resulted in a comparable reduction of total RNA 
levels in Wt and Aptx
-/-
 cells, subsequent incubation in H2O2-free media revealed a significant (p < 
0.01, Students T-test) deficit in RNA synthesis in Aptx
-/-
 MEFs (Fig. 4.2C). These observations 
suggest that Aptx
-/-
 cells have more unrepaired oxidative DNA breaks after damage, which require 
repair before transcription can continue.  
 
Elevated intracellular oxidative load reveals a repair and survival defect in Aptx
-/-
 MEFs  
 
Previous reports using human cells and primary neural cells (El-Khamisy et al. 2009) have found no 
repair defect in aprataxin-deleted cells, using comet assays. In order to test the hypothesis that Aptx 
repairs a subset of oxidative DNA breaks in vivo, which becomes critical for cell function and 
survival in situations of high rates of intracellular oxidative stress, Aptx
-/-
 mice were generated in 
which a mutant form of superoxide dismutase SOD1
G93A
 was expressed to increase endogenous 
oxidative load. SOD1
G93A
 is associated with elevated levels of oxidative stress, oxidative DNA 
breaks and cellular dysfunction (Howland et al. 2002; Barbosa et al. 2010). MEFs were isolated and 
expression of normal murine Sod1 and mutant human SOD1 (SOD1
G93A
), or not, was confirmed by 
immunoblotting (Figure 4.3 A). No Wt cell line was available as a result of the Aptx/SOD1
G93A
 
breeding carried out but since experiments by myself and others had shown no difference in repair 
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of oxidative breaks in Aptx
-/-
 cells relative to Wt cells by survival assay (Figure 4.1 D) (Clements et 
al. 2004) we went ahead with repair assays, focussing on the effect of aprataxin loss in a mutant 
SOD1 background in cells. We next compared SOD1
G93A
 and Aptx
-/- 
SOD1
G93A
 cells for the ability 
to repair oxidative SSBs induced by IR or H2O2 using alkaline comet assays. No significant 
difference in repair rates was observed between Aptx
-/- 
SOD1
G93A
 compared to SOD1
G93A
 cells 
following γ-irradiation (Figure 4.3 B-C), but a significant delay in repair was measured at 30 mins 
after H2O2 in the double mutants compared to aprataxin-proficient SOD1 mutants (Figure 4.3 D-E).  
 
To test whether this delay in repair of oxidative damage at short time-points would translate into a 
survival defect, clonogenic survival assays were performed. A significant (p = 0.03, Student’s T-
test) survival defect after the maximum dose of X-ray irradiation used (5Gy) was measured in the 
double mutants compared with aprataxin-proficient SOD1 mutants (Figure 4.4 A). Interestingly 
though, even at moderate doses of H2O2 the double mutants showed a significant survival defect 
(p = 0.015, Student’s T-test) at 100 μM and p = 0.02 at 200 μM) compared with aprataxin-proficient 
SOD1 mutants (Figure 4.4 B).  
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4.4  Discussion 
 
Aprataxin-deletion alone conferred no survival defect following gamma-irradiation or H2O2, in 
agreement with previous reports (Figure 4.1 C and D)(Clements et al. 2004). Survival and comet 
assays demonstrated a small but signficant defect in aprataxin-deleted cells in a SOD1
G93A
 
background in MEFs following exposure to physiological levels of oxidizing agent (100-200 μM 
H2O2 in survival assays, 90 μM in comet assays), but not to X-ray or γ-irradiation, respectively. 
This likely reflects the different the types of damage inflicted by IR and H2O2. Although the extent 
and types of damage caused to DNA by each of these damaging agents is not well understood, H2O2 
is believed to result in more oxidative base damage and a higher SSB:DSB ratio of damage than IR 
(Lindahl 1993). Further work is needed to establish whether or not the defects demonstrated here 
are relevant to AOA1 disease pathology. The cerebella of aged SOD1
G93A
Aptx
-/-
 mouse models 
should be analysed for evidence of enhanced sensitivity to oxidative damage. 
 
It should be noted that the extent of the effect of the SOD1
G93A
 mutant is not yet thoroughly 
understood. Elevated levels of highly toxic hydroxyl radicals produced by the mutant via the Fenton 
reaction (Mao et al. 1993) are associated with oxidative damage to DNA and hypersensitivity to 
oxidizing agents (Barbosa et al. 2010). But the oxidation of other biomolecules including lipids and 
proteins have also been observed, all eventually leading to neurodegeneration in a pathophysiology 
reminiscent of that of ALS in humans - hence it has been widely used around the world to as an 
ALS disease model (Gurney et al. 1994). Thus, we cannot rule out further neurotoxic effects of the 
mutant that may sensitise to aprataxin-deletion, besides DNA oxidation. Its induction of 
mitochondrial dysfunction may be especially relevant, as aprataxin is implicated in the repair of 
mtDNA (Sykora et al. 2011) and this may explain the heightened sensitivity to oxidising agents.  
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There may be a positive feedback loop whereby reactive oxygen species lead to mitochondrial 
dysfunction, which leads to respiratory burst, generating more reactive oxygen species. We may 
envisage a similar situation in aged cerebellar tissues with high metabolic rate and transcript 
turnover and a loss of aprataxin function. The finding that senescence is accelerated and 
transcription recovery following oxidative damage is impaired in aprataxin-deleted cells is 
intriguing. Further work is needed to establish whether or not the effects observed here in MEFs are 
reflective of the situation in vivo and whether or not they are relevant to AOA1 disease progression. 
Detailed analyses of the tissues affected and of the corresponding tissues in animal models will help 
to address these questions in the future. 
 
Together, these data suggest that elevating endogenous oxidative stress by expressing SOD1
G93A
 
sensitises Aptx
-/-
 cells to oxidative DNA damage and may provide a useful model of elevated 
oxidative stress levels in cycling cells. 
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Chapter Five: Results (3) 
 
Analyses of the 
consequences of expression 
of a toxic form of SOD1 in 
aprataxin knockout models 
 
 
113 
 
5.1   Introduction 
 
The DNA end processing abilities of aprataxin have been well characterized in vitro 
(Ahel et al. 2006; Takahashi et al. 2007; Reynolds, El-Khamisy, and Caldecott 2009) 
And there is growing evidence to suggest that it protects both nuclear and mitochondrial 
DNA against genotoxic stress (Gueven et al. 2004; Mosesso et al. 2005; Sykora et al. 
2011) and has roles in the coordination of parallel pathways (Wei and Englander 2008; 
Rass, Ahel, and West 2007; Kijas et al. 2006; Daley, Wilson, and Ramotar 2010). But 
how these activities function in the context of DNA repair in vivo, what the downstream 
cellular effects are, and why aprataxin dysfunction results in cerebellar 
neurodegeneration remains largely unknown. To address this issue, we used the cell 
stress model described in the previous chapter (transgenic expression of human 
SOD1
G93A
) to further examine the downstream effects of loss of aprataxin in cells under 
continuous oxidative stress.  
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5.2   Aims of this chapter 
 
The aims of this chapter were to gain more insight into the observations that aprataxin 
deletion is associated with an accelerated senescence phenotype and a transcription 
recovery defect following oxidative damage in primary fibroblasts in vitro (Chapter 4). 
 
Oxidative stress has been associated with telomeric instability and reduced telomerase 
activity (Makino et al. 2011), so the first aim of this chapter was to assess the impact of 
aprataxin loss on telomeric length/stability. Next: senescence is associated with cell 
cycle arrest in response to DNA damage, so cell cycle analysis was a natural next step 
in the investigation. Cellular senescence and somatic growth attenuation at the level of 
the whole organism has also been associated with persistent transcription-blocking 
lesions - via a decrease in IGF-1 and GH signalling (Garinis et al. 2009; Niedernhofer et 
al. 2006) so tissues from the livers from aged mice were harvested and examined for 
IGF1 expression. 
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5.3   Results 
 
Effects of aprataxin-deletion are not due to major telomeric instability  
 
Following the observation that Aptx
-/-
 MEFs senesce faster than wild-type counterparts 
the mechanisms of cellular senescence were considered. Senescence can result from 
multiple different triggers and by several different pathways, as reviewed by (Collado 
and Serrano 2006), including telomeric instability. Senataxin, a putative DNA/RNA 
helicase related to aprataxin, has been suggested to play a role in telomere stability (De 
Amicis et al. 2010). To test whether a lack of aprataxin was affecting telomere stability 
the telomere length of 'aged' (P8) mutant MEFs was compared using the TeloTAGGG 
Telomere Length Assay (Roche). Although there were noticeable differences in the 
telomeric signals produced by each strain (Figure 5.1, triplicates 1 and 2 compared to 
triplicates 3 and 4) no difference was observed between Wt and Aptx
-/-
; and SOD1
G93A
 
and Aptx
-/-
SOD1
G93A
. To test whether telomere shortening might be triggered by 
exposure to exogenous sources of DNA damage, we repeated the analyses following 
exposure to 50μM H2O2 for 10 minutes for 3 consecutive days. Although a slightly 
longer smear of signal – suggesting the presence of shorter telomeric sequences was 
observed in the treated compared to untreated SOD1
G93A
 and Aptx
-/-
SOD1
G93A
 cells, 
there was no dramatic difference in telomeric length detected between the Wt and Aptx
-
/-
 cells employed without and with H2O2 treatment (Fig. 5 (A+B)), suggesting that the 
observed senescence in Aptx-/- cells is not attributable to acute telomeric instability. 
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Effects of aprataxin-deletion are not due to major cell cycle disruption 
 
Next, FACS analysis was performed on cultured MEFs (passage 4) to ascertain whether 
defective cell cycle progression was causing the observed senescence. All mutant 
populations had a lower proportion of cells in G1 phase and a higher proportion of dead 
cells than Wt cells (Fig. 5.3). The SOD1
G93A
 populations had by far the highest 
proportion of dead cells in both experiments. The double mutant Aptx
-/-
SOD1
G93A
 cell 
populations showed a modest accumulation in S and G2 phase and a concurrently lower 
proportion of dead cells, relative to their aprataxin-proficient counterparts.  
 
IGF-1 expression is down-regulated in Aptx-/-SOD1G93A mouse liver  
 
Recent reports suggesting a link between DNA damage repair defects and somatotropic 
growth attenuation (measurable by IGF-1 expression levels) prompted questions as to 
whether this may be connected with the observed accelerated senescence and reduced 
transcription recovery rates in Aptx
-/-
 cells (Fig. 4.2). To test this hypothesis samples of 
liver tissues from adult (3 months old) Wt, Aptx
-/-
, SOD1
G93A
, and Aptx
-/-
SOD1
G93A
 
mice were tested for IGF-1 expression levels. PCR amplification of IGF-1 and β-actin, a 
housekeeping gene, revealed a possible reduction of IGF-1 expression in the Aptx
-/-
SOD1
G93A
 tissues compared to Wt tissues (Fig. 5.5 A). These observations were 
confirmed by quantitative PCR analyses of cDNA generated from adult mouse livers 
(Fig. 5.5 B). Our data revealed a significant (Student's T-test: p < 0.001) down-
regulation of IGF-1 in the double mutants compared to all the other genotypes.  
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5.4    Discussion 
 
The telomeric length assays showed no observable difference between the mutants 
following treatment with - a concentration of 50μM H2O2  below those that produced a 
survival defect in double mutants (Figure 4.4 B) but capable of producing a 
transcription recovery defect (Figure 4.2 C). Possibly a different treatment regimen 
would have produced an observable difference but if telomeric instability were a major 
cause of the acceleration in senescence observed without the use of exogenous 
damaging agent (Figure 4.2 A and B), we would expect an observable effect after 3 
consecutive days of 10 min 50μM H2O2 treatments. We cannot rule it out as a possible 
cause either, as the amount of telomeric instability necessary to trigger senescence 
relative to the sensitivity of the assay is not clear. What is clear is that there is no major 
destabilization of telomeres with loss of aprataxin, in a SOD1
G93A
 background or not, 
and with oxidative damage, or not.  
 
There did appear to be some modest disruption to cell cycle progression in the mutant 
MEFs according to the FACS analysis readouts (Figures 5.3 and 5.4). Interestingly, the 
double mutants' FACS profiles appeared 'healthier' than those of the SOD1
G93A
 MEFs, 
prompting the question: Is the level of damage sustained in these aprataxin-deleted 
stressed cells reaching a threshold level at which a compensatory mechanism is 
protecting the cells from dying? Or is aprataxin involved in an apoptotic pathway 
induced by levels of damage sustained in SOD1
G93A
 cells so that its deletion is 
protecting them from dying? If deletion of p53 were found to confer protection against 
cell death in mutant cells, then this would support the notion of a programmed cell 
death in response to elevated rates of DNA damage in mutant cells. 
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The down-regulation in IGF-1 expression observed in the double mutants offers a 
possible explanation, and adds strength to previous reports that persistent transcription-
blocking DNA lesions trigger somatic growth attenuation (Garinis et al. 2009; 
Niedernhofer et al. 2006). This marked difference in IGF-1 expression suggests a 
specific effect signifying a switch from growth to somatic preservation associated with 
extended longevity and likely correlates with the accelerated senescence observed in 
aprataxin-deleted cells in vitro. 
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Chapter Six 
 
Discussion 
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6.1       Effects of aprataxin loss in vitro 
 
The observation that aprataxin facilitates gap filling by Pol β at single-strand breaks in vitro is 
intriguing, and supports previous reports that aprataxin acts in concert with parallel repair 
processes (Daley, Wilson, and Ramotar 2010). Aprataxin and Pol β both interact with the 
XRCC1/LigIII SSBR protein complex (Figure 3.9) so in cells, any interaction between them 
may be facilitated or impaired by the multi-protein complex in which they both operate at DNA 
breaks.  
The XRCC1/LigIII complex control various aspects of SSBR, such as the rate of recruitment of 
further proteins to the complex and choice of short or long patch repair, via PAR chain synthesis 
by PARP1 (Caldecott et al. 1996, Caldecott 2003, Fisher et al. 2007, Petermann et al. 2005). 
The enhancement of 3' extension by Pol β in the presence of recombinant aprataxin and no 
lysate, however (Figure 3.8), suggests that they might interact directly. Further work could 
include yeast two-hybrid analyses and co-immunoprecipitations to investigate the interaction 
between aprataxin and polymerases, both DNA and RNA. Pol β deletion is embryonic lethal, 
but Pol β expression may be suppressed in specific tissues using Cre-Lox site-specific 
recombinase technology. It would be interesting to do brain-specific knockout of Pol β, to test 
whether this sensitises aprataxin deficient post-mitotic tissue in animal models. 
Although this thesis has focussed on the role of aprataxin in SSBR, it should be noted that 
aprataxin is also active at double-strand breaks and present in the DSBR protein complex 
(Figure 3.10), as are the replicative polymerases, Pol λ, Pol μ and TdT. It would be interesting 
to find out if a similar interaction takes place between aprataxin and the polymerases involved 
in DSBR. This could be tested using a similar in vitro repair assays as described here. The repair 
of double-strand DNA substrates may be measured in the presence and absence of aprataxin. 
Interactions between aprataxin and polymerases may be relevant to transcription-coupled repair; 
aprataxin may interact with RNA polymerase. SSBR is suggested to work in conjunction with 
transcription machinery (Banerjee et al. 2011; El-Khamisy 2011) and data presented in this 
thesis suggests that aprataxin facilitates transcription recovery following oxidative damage 
(Figure 4.2C). It would be interesting to further investigate this observation to find out whether 
aprataxin interacts with RNA polymerase II by yeast two-hybrid assay and/or 
co-immunoprecipitation. 
 
Reynolds et al. showed that in the absence of aprataxin, short-patch repair of a 5’AMP SSB was 
blocked in the presence of elevated levels of ATP, due to low levels of non-adenylated ligase 
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(Reynolds et al. 2009). That suggests that aprataxin is of specific importance to SSBR at high 
levels at ATP, which may prove to be relevant to AOA1 pathology. It would be interesting to do 
similar in vitro experiments at a range of ATP concentrations to see if this has an effect on 
SSBR sub-pathway choice. 
 
 
6.2     Effects of aprataxin loss in cells 
 
 
The findings presented in this thesis show that loss of aprataxin has an impact on cell growth 
and senescence. Further findings from experiments in cells offer possible reasons for the slow 
growth observed. Namely, the delay in transcription recovery following damage (Figure 4.2C) 
and the DNA repair and survival defect in cells exposed to oxidative stress (Figures 4.3 and 
4.4). The in vitro data presented in Chapter 3, which show that aprataxin facilitates gap filling 
by Pol β, suggest that the effects of aprataxin loss at SSBs may extend beyond the defective 5' 
end processing that has previously been associated with aprataxin loss and include an effect on 
gap filling. This may be due to direct interaction between the proteins, indirect interaction via 
one or more intermediaries, or steric hindrance. It is possible that a ligase may adenylate the 5’ 
terminus of a SSB and remain attached until a proximal 3’P is available for ligation. If so, it 
may physically hinder the polymerase: an effect resolvable by the action of aprataxin. 
Electrophoretic mobility shift assays may be used to find out if this is the case.  
The finding that IGF-1 expression is dramatically reduced in aprataxin-knockout animal models 
expressing a toxic SOD1 mutant is consistent with the observed slow growth and accelerated 
senescence. Of course, the slow growth observed in aprataxin-deleted cultured cells is not 
necessarily as a result of a similar down-regulation of IGF-1. Even so it represents a similar 
pattern: a deceleration of cell growth signalling with aprataxin-deletion. 
This somatic growth attenuation is well tolerated, as evidenced by the lack of disease phenotype 
in animal models. Indeed this response to DNA damage has been observed by others to guard 
against further DNA damage, extending lifespan, alongside accelerating ageing (Van Der 
Pluijm et al. 2007; Niedernhofer et al. 2006; Hoeijmakers 2007). This may help to explain the 
lack of elevated mutation rate in AOA1 pathology, as slowed replication and growth would 
result in lowering the rate of mutation. 
Regarding the single-strand break repair and survival defect, and the attenuation of IGF-1 
expression presented in this thesis, it is tempting to surmise that the delay in repair of 
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single-strand breaks (and correlating survival defect) following oxidative damage is sufficient to 
produce the attenuation in IGF-1 expression observed in adult animal models. This may be the 
case, but the SOD1
G93A
 mutant has other effects besides DNA oxidation. Therefore we cannot 
rule out the possibility that there is another unknown effect that, in combination with aprataxin 
loss leads to the observed somatic growth attenuation. Further evidence linking the IGF-1 
expression suppression to oxidative damage would be necessary to rule out this possibility.  
Transcription-coupled repair is understood to prioritise the repair of transcribed genes, thereby 
conserving DNA repair capacity for where its most needed (Tornaletti 2009). Aprataxin has 
been shown to associate with the nucleolar proteins nucleolin, nucleophosmin and upstream 
binding factor (UBF) that have been associated with transcription (Becherel et al. 2006; Gueven 
et al. 2004), presenting the possibility that aprataxin has a role at sites of high transcriptional 
demand. The cerebellum is thought to be extremely transcriptionally active so its role in 
transcription is likely to be especially important for the pathology of the disease. Further work is 
needed to investigate aprataxin's role in transcription-coupled repair. DNA microarray 
experiments using cell cultures or tissues from animal models could be very informative in 
measuring gene expression levels across the genome. 
 
 
6.2.1     Importance of oxidative lesions in the brain 
 
 
Since the brain is largely protected from exogenous DNA damage sources by the cranium and 
the blood-brain barrier, DNA lesions in the brain result predominantly from endogenous 
sources. The high rate of oxidative metabolism in the brain and the resulting high concentrations 
of reactive oxygen species produce high levels of DNA damage, especially single-strand breaks 
and oxidative damage (Lindahl 1993; De Bont 2004). Robust DNA repair processes are 
generally associated with replication in proliferating cells due to the presence of a sister 
chromatid to use as a template (Barnes and Lindahl 2004), so the post-mitotic neurons in the 
adult brain are believed to be especially reliant upon the repair mechanisms at their disposal. If 
AOA1 is indeed caused by defective DNA repair, then the tissue-specific neurodegeneration 
observed in the cerebellum of AOA1 patients suggests that the critical lesion is oxidative in 
nature and requires processing by aprataxin. 
The synergistic toxicity of mutant SOD1 expression (which induces oxidative DNA damage) 
and aprataxin-deletion in cells is consistent with the above premise. Furthermore, it raises the 
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question: could SOD1-related activities play a role in AOA1 pathology? SOD1 and catalase are 
both important antioxidant enzymes that function in conjunction with one another. SOD1 is a 
scavenger of superoxide radicals but produces hydrogen peroxide. Under conditions where 
superoxide radicals are in excess and iron is available, the formation of toxic hydroxyl radicals 
from hydrogen peroxide by SOD1 via the Fenton reaction outweigh the beneficial effects of 
superoxide scavenging – a mechanism understood to be stimulated by the G93A mutation 
(Chang et al. 1988; Mao et al. 1993; Cleveland and Liu 2000) (Figure 1.22). 
 
Transfection of mouse epidermal cells with catalase protects against toxicity associated with 
mutant SOD1 transfection, suggesting that catalase can compensate for harmful by-products of 
SOD1 activity (Amstad et al. 1991). Englander finds that catalase levels in the cerebellum are 
markedly elevated relative to other tissues - presumably as a cellular response to stress to 
mitigate the elevated levels of oxidative stress in these cells. Overexpression of catalase has 
been reported to increase life expectancy by almost 20% in mice (Schriner et al. 2005). It would 
be interesting to test catalase expression levels in SOD1
G93A
/Aptx
-/-
 animal models - in the brain 
and other tissues. We might expect an up-regulation in double mutants in response to higher 
levels of oxidative stress and impaired ability to repair oxidative DNA damage.  
 
Further studies are required to understand the contribution of SOD1/catalase imbalance to toxic 
DNA oxidation by ROS and to investigate possible ways to slow the accumulation of damage. 
If SOD1/catalase imbalance and Fenton-derived ROS are found to be responsible for neuronal 
decline, then antioxidants and/or metal chelators may prove useful in extending the life of 
repair-defective neurons. 
 
 
6.2.2     Downstream effects of aprataxin loss on cellular processes 
 
 
The most note-worthy effects of aprataxin loss on downstream cellular processes presented in 
this thesis - namely, the slowed population doubling in cultured cells, the accelerated 
senescence, the delay in transcription recovery, and the attenuation of somatic growth signalling 
with concomitant expression of a toxic SOD1 mutant, all present promising avenues for further 
investigation. Conclusions from results obtained using the SOD1 mutant should be made with 
caution due to the unspecific nature of its effects. Still, all of the effects observed seem to be 
different readouts of the same overall cellular response to accumulating DNA damage - a switch 
to slow cell growth and other DNA-related processes in order to maintain genome stability.  
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This effect has also been observed in response to NAD
+
 depletion in the nucleus and cytoplasm 
following caloric restriction or exercise (Yang et al. 2007) and is thought to be due to activation 
of the NAD
+
 salvage pathway in the mitochondria. Before discussing this more, I will first 
consider the DNA repair role of aprataxin in the mitochondria.  
 
 
 
6.2.3     Effects of mitochondrial dysfunction 
 
 
 
The results presented in this thesis do not address the role of aprataxin specifically at 
mitochondrial DNA, but it should be noted that aprataxin has roles in repairing both nuclear and 
mitochondrial DNA (Sykora et al. 2011). Mitochondrial DNA is believed to be especially 
threatened by oxidative damage - due to the high levels of ROS present in the mitochondria, and 
the lack of protective histones bound to mtDNA. On the other hand, nuDNA is much more 
sensitive to oxidative damage, whereas the multiple copies of mtDNA and limited repair 
capacities thereof mean that a high level of oxidative breaks can persist without critically 
disrupting mitochondrial function. AOA1 shares some characteristics of one particular type of 
mitochondrial disease, known as Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP), which 
results from a reduced ability of the ATP synthase enzyme in the mitochondria to generate ATP 
(Santorelli et al. 1997). It is likely that mitochondrial dysfunction accounts at least in part to 
AOA1 pathogenesis, although there is currently not enough evidence to be able to fully attribute 
the pathology to either compartment. Since aprataxin is present in both compartments, it is 
likely required for optimal function of both nuclear and mitochondrial processes. 
 
 
6.2.4     PARylation, NAD
+
, and sirtuin signalling 
 
 
PARylation plays diverse roles in many molecular and cellular processes, including DNA 
damage recognition and repair, chromatin modification, transcription, and cell death 
pathways (Kim, Zhang, and Kraus 2005). These processes are involved in many 
physiological and pathophysiological outcomes, including genome maintenance, 
carcinogenesis, ageing, inflammation, and neuronal function (Kim, Zhang, and Kraus 2005). 
Generation of PAR for polymerisation by PARPs, is dependent upon NAD
+
 (Nishizuka 
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1967). One of the major causes of cell death due to genotoxic stress is hyperactivation of the 
NAD
+
-dependent PARP-1, leading to a depletion in nuclear and cytoplasmic NAD
+
 and 
resulting in the translocation of apoptosis inducing factor (AIF) from the mitochondrial 
membrane to the nucleus, triggering apoptosis (Yu et al. 2002). This may explain the higher 
cell killing after damage observed in the double mutants (Figure 4.4). 
 
Prolonged PARylation resulting from persisting SSBs such as those observed in the data 
presented in this thesis (Figure 4.3E) may be sufficient to deplete NAD
+
 levels in neurons, 
to a level at which sirtuins are activated. The sirtuins are a highly conserved family of 
NAD
+
-sensitive deacetylases and mono-ADP-ribosyltransferases that are implicated in 
transcriptional silencing and longevity under conditions of cell stress and caloric restriction 
(Imai et al. 2000). IGF-1 suppression has been associated with sirtuin activation 
(Niedernhofer et al. 2006; Mostoslavsky et al. 2006; Cohen et al. 2009). 
 
Hence, the IGF-1 down-regulation observed in adult animal models (Figure 5.5) may be 
linked to the persisting SSBs observed in cultured cells of the same genotype (Figure 4.3E). 
Currently little is known about the exact amount of NAD
+
 present in the cellular 
compartments, or the amount of DNA damage required to impact on NAD
+
 levels. If 
mitochondrial dysfunction as a result of NAD
+
 depletion is to blame for 
aprataxin-deficiency related pathology, then we might expect sirtuin agonists to prove useful 
in delaying symptom onset in patients. Several such compounds exist, including the Sirt1 
agonist SRT1720, which has demonstrated improvement in mitochondrial capacity and 
oxidative metabolism in rats and mice (Milne et al. 2007; Feige et al. 2008; Yoshizaki et al. 
2010). 
 
 
6.3.     Implications for understanding of aprataxin function and AOA1 
 
 
The data presented in this thesis may prove to be helpful in developing understanding of 
aprataxin function and AOA1. Together, they suggest that although loss of aprataxin function is 
not harmful to cells under most conditions, concurrent oxidative damage can impact on cell 
function and accumulation of damage over long time periods can lead to several effects 
associated with ageing. I would therefore like to suggest that AOA1 disease progression may 
manifest due to reiterative cycles of DNA damage and response – leading to increasing loss of 
function and cell death: a cerebellum-specific progeroid syndrome (Figure 6.1). 
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Although this thesis has not addressed questions of aprataxin function at DSBs, it is recruited to 
DSBs and can bind and cleave blunt and 'sticky end' double stranded DNA-adenylate substrates 
(all be it with considerably lower affinity than single-strand break substrates). The vast majority 
of DNA strand breaks induced by oxidative damage (the principle type of damage believed to 
be responsible for AOA1 pathogenesis) are SSBs, but about one in 2000-3000 are DSBs (Olive 
and Johnston 1997; Bradley and Kohn 1979) More SSBs may be converted to DSBs by 
collision with the transcription machinery or by SSBs on opposite strands occurring close to one 
another. Although rare, these are likely to be highly toxic breaks and likely to contribute in part 
to AOA1 pathogenesis. 
 
Treatment for AOA1 is currently very limited. Some AOA1 patients display coenzyme Q10 
(CoQ10) deficiency. In these cases, oral CoQ10 supplementation can improve clinical outcome 
(Quinzii et al. 2005). Oral antioxidant supplements are used, with limited improvement in 
clinical outcome (Palau and Espinós 2006). Now that patients may be identified by genetic 
testing prior to the onset of symptoms, prophylactic treatment may significantly delay or even 
prevent disease onset, once the disease mechanism is clearly delineated. If oxidative breaks 
prove to be critical in AOA1 pathogenesis, antioxidant supplementation from infancy may 
prove useful in delaying symptom onset. If the absence of aprataxin and unavailability of 
non-adenylated ligase in cellular situations of elevated ATP levels proves to be critical, then 
pharmaceutical intervention favouring the non-adenylated ligase may be beneficial. If sirtuin 
signalling or SOD1/catalase imbalance prove to be relevant to the human disease, then 
pharmaceutical intervention may be designed to target these. In the longer term we may look to 
gene-therapy approaches to treat the disease. For example, tissue-specific antioxidant expression 
or DNA repair factor complementation. 
 
 
6.3.1     Outstanding questions 
 
 
Despite the progress that has been made over the last decade in understanding the molecular 
basis of AOA1, there are several important outstanding questions. The site-specific nature of the 
neurodegeneration observed in AOA1 remains to be explained. If the impact of aprataxin loss 
on cellular responses to oxidative damage presented here is true also in a human adult, then they 
may offer explanations to this question., It would be interesting to know what levels of 
oxidative damage may be tolerated in the human cerebellum to what extent defective 
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SSBR/transcription dysruption/accelerated senescence is tolerated before impacting on cell 
function. These issues are currently impossible to resolve absolutely due to the inaccessibility of 
human tissues but may be approximated using cellular and animal models. 
 
The reason for the lack of elevated mutation rate and cancer predisposition in AOA1, a common 
feature of other human disorders associated with DNA repair defects, has not so far been 
resolved. The acceleration in senescence and attenuation of somatic growth, are consistent with 
a protection against expected elevated mutation rate. It would be interesting to find out if there 
are similar effects in human AOA1 patients. If a similar effect is found in human AOA1 
patients, it may help to explain the lack of elevated malignancy and may even help to explain 
the site-specific nature of the neurodegeneration observed in AOA1. Further research into the 
role of growth hormone signalling on replicating cells and on complex neural systems will be 
necessary to address these questions. 
 
 
6.3.2     Concluding remarks 
 
 
The contribution of persisting DNA damage to ageing, and various age-related pathologies is a 
subject of intense interest. The DNA repair system shows remarkable capacity to adapt to 
specific situations and compensate for defects at the level of individual DNA strand breaks. The 
highly conserved metabolic response to persisting DNA damage, whereby attenuation of the 
IGF-1/GH somatic growth signalling pathway re-allocates resources from growth to somatic 
preservation and life extension, is an example of a compensatory response of a much larger 
scale, affecting the whole organism. Pharmaceutical or gene-therapy approaches to harnessing 
these processes may provide relief from progeroid syndromes and age-related disease. 
 
Research into the mechanisms of neurological disease and efforts directed at slowing or 
preventing disease progression offer hope for treating debilitating neurodegenerative diseases. 
More generally, they offer hope for improving the robustness and extending the life span of the 
human brain.  
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Chapter One 
 
Introduction 
 
Figures 
2 
Figure 1.1   Cellular outcomes of DNA damage. 
 
If left unrepaired, accumulated DNA damage may cause a cell to become apoptotic, senescent, 
or cancerous. The rate at which a cell is able to efficiently repair DNA is contingent on many 
factors including cell type and age. 
3 
Figure 1.2   DNA lesions and their predominant repair mechanisms 
  
The nature and extent of DNA damage depends upon the source of the 
damage. Under normal circumstances the nature of the lesion dictates 
which repair pathway will repair it.             
       From Vermeulen et al. 2000 
Figure 1.3    Structures of the most common chemical moieties at the 3’ termini of SSBs 
 
3’hydroxyl (3’OH), 3’phosphate (3’P), 3’phosphoglycolate (3’PG), 3’tyrosyl (3’Y) - which may 
include a variably degraded Top1 polypeptide (R), and  3’αβ unsaturated aldehyde (3’PUA) are all 
common 3’ SSB termini. 
3’ hydroxyl 
3’ phosphate 
3’ phosphoglycolate  
3’ αβ 
unsaturated 
aldehyde 
3’ tyrosyl 
R 
5 
Figure 1.4   Structures of the most common chemical moieties present at the 5’ termini of DNA SSBs 
 
5’phosphate (5’P), 5’hydroxyl (5’OH), 5’ deoxyribose phosphate, (5’dRP), 5’aldehyde (5’AH) and 
5’adenosine monophosphate (5’AMP). Structures in red indicate unligatable damaged termini that require 
processing before ligation. 
6 
Figure 1.5   Model for mammalian SSBR at indirect and direct short-patch single strand breaks  
 
The main repair proteins involved in the repair of indirect (in this case BER-induced) and direct ‘short 
patch’ single strand breaks are depicted at the common steps of repair, Detection, End Processing, 
Gap Filling and Ligation. The end processing factors used depend on the chemistry of the termini at 
the break. AP = Abasic site APE1 = Apurinic/apyrimidinc endonuclease 1 dRP=deoxyribose 
phosphate Polβ = polymerase β APTX = aprataxin PNK = polynucleotide kinase. The processes 
involved are reviewed in detail in Caldecott, 2003.                                 
Detection 
End Processing 
Gap Filling 
Ligation 
Adapted from Caldecott, Cell, 2003 
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proteases 
TDP-1 
Figure 1.6  Repair of Topoisomerase 1 cleavage complexes by proteases and TDP-1 
 
Proteases degrade the Top1 protein to leave a tyrosine bound on the 3’ terminus of the lesion. 
TDP-1 cleaves the phophotyrosyl bond to release tyrosine and restore the ligatable 3’P terminus. 
In cells TDP-1 performs this action in concert with the SSBR complex. 
+ 
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Figure 1.7   Formation of 8-oxo-G and thymine glycol by hydroxyl radical attack of 
guanine and thymine  
 
The most common oxidative base damage, 7,8-dihydro-8-oxoguanine (8-oxo-G); and 
thymine glycol; are produced by the attack of guanine and thymine by hydroxyl radicals. 
guanine 
+ OH • . 
+ OH • . 
H 
8OG T 
A A 
8OG 
C 
DNA 
replication 
DNA 
replication 
Figure 1.8  The mutagenic potential of 3-oxo-guanine 
 
The incorporation of adenine opposite 8-oxo-G can lead to a G → T mutation after two 
rounds of replication. 
Adapted from van 
Loon, 2010 
9 
Figure 1.9  Eukaryotic (Mammalian) Nucleotide Excision Repair 
A) Damage is sensed through either the detection of stalled polymerase by the CS proteins 
(Transcription Coupled Repair) or through the detection of helical distortions by XPE and/or 
XPC (Global Genomic Repair). Chromatin remodelers, not shown here for simplicity, are 
inolved in reshaping the chromatin landscape to facilitate downstream processes. 
B) The two pathways converge with the recruitment of TFIIH, carrying the helicases XPB and 
XPD which serve to unwind the double helix and allowing the recruitment of RPA, XPA and 
XPG. 
C) The hucleases XPF-ERCC1 and XPG coordinate their incisions on the lesion containing strand 
with the 5’ incision by XPF preceding the 3’ incision by XPG (5’ and 3’ are in relation to the 
position of the lesion). 
D) The resulting gap in the DNA double helix is then resynthesized by DNA polymerases: Polδ, 
Polε, and Polκ. This is then followed by ligation and the restoration of the chromatin structure. 
The choice of polymerase and ligase is influenced by whether the cell is actively cycling or in a 
non-cycling state.                                                                                          Cloney 2011 10 
Figure 1. 10   Phylogenetic tree of aprataxin, a member of the histidine triad family of 
nucleotide hydrolases and transferases   
 
Numbers refer to confidence of shared ancestry, out of 1000. 
The protein sequences from each branch (indicated by the bracket) including aprataxin were aligned 
by ClustalW then used to build a Neighbor Joining tree (with pairwise deletion) to investigate how 
these sequences relate to each other using human CHK2 protein as the root. The boot- strap test was 
applied with 1000 replicates, and the values are indicated on the top at each node. 
Kijas 2006 
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        FHA                         NLS                                HIT                                       ZNF 
Binds: XRCC1 (SSBR) 
           XRCC4 (DSBR) 
           MDC1   (DSBR) 
Most AOA1 mutations 
Functional domain 
Adapted from Caldecott, 2008 
Figure 1.11  Illustration of the aprataxin protein with known domains indicated  
 
FHA = Forkhead Associated domain, responsible for binding to XRCC1 during SSBR and XRCC4 
during DSBR. NLS = Nuclear Localizing Signal HIT = Histidine Triad, contains the catalytic 
histidine triad (indicated by a red box). ZNF = Zinc Finger, important for optimal function.  
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Figure 1.12  Normal ligation of a DNA nick by DNA ligase 
 
At a DNA nick containing a 5’P  and a 3’OH, an adenylated ligase transfers an AMP 
group to the 5’ terminus of the nick, which is then attacked by the 3’OH to reseal the nick. 
AMP + 
5’ 
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5’ 3’ 
P 
3’ 
5’ 
AMP 
5’ 3’ 3’ 5’ 
AMP 
Figure 1.13  Abortive nick ligation and formation of a 5’AMP 
 
During an abortive ligation reaction, an AMP group is transferred from an adenylated ligase 
to the 5’P of a single strand break containing a damaged 3’ terminus – shown in red.  
The damaged 3’ terminus may be any moiety other than a 3’OH. 
Ligase 
Ligase 
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5’ 
AMP 
Aprataxin 
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Step 2 
+ P Aprataxin 
Aprataxin 
Figure 1.14  Schematic to illustrate the resolution of abortive ligation intermediates by aprataxin  
 
Step 1: Attack of the 5’ adenylated phosphate and transfer of the AMP onto aprataxin’s active site 
histidine triad. Step 2: Hydrolysis of the 5’phosphohistidine to release AMP and recycle aprataxin.  
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Figure 1.15  Schematic to show long-patch and short-patch repair of a single strand break  
 
During long-patch repair, the polymerase fills the gap and displaces the 5’ dRP and several 
nucleotides. The resulting flap is cleaved by a flap endonuclease before a ligase seals the remaining 
nick. During short patch repair the polymerase simply fills the gap and a ligase seals the nick.  
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Figure 1.16  General scheme of classical non-homologous end-joining  
 
DNA double strand breaks are detected by the Ku 70/80 heterodimer, resulting in the 
recruitment of DNA-PKcs and the XRCC4/DNA ligase IV complex. DNA ends processed 
by nucleases during the synaptic complex if necessary (not shown here for simplicity).     
     Leber, 1998.  
17 
Figure 1.17   General scheme of homology-directed repair of DNA double strand breaks 
 
DNA double strand breaks are detected by the Ku 70/80 heterodimer, resulting in the 
recruitment of DNA-PKcs and the XRCC4/DNA ligase IV complex. DNA ends processed by 
nucleases during the synaptic complex if necessary (not shown here for simplicity).     
    
   Summarized from Hartlerode and Scully, 2010 
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Figure 1.18   Telomeres protect genomic information 
   
Short telomeres activate a DNA-damage response that leads to apoptosis and senescence. 
As cells divide, telomeres shorten because of the end-replication problem. Critically, short 
telomeres recruit DNA damage proteins that activate cellular programs of apoptosis or 
senescence. This cellular response manifests as organ failure in clinically recognisable 
syndromes of telomere shortening.  
From Armanios, Annual Review of Genomics and Human Genetics, 2009 
19 
© 2008 Sinauer Associates Sadava, D. et al. Life: The Science of Biology, 8th ed. 
(Sunderland, MA: Sinauer Associates and W. H. Freeman & Company), 248.  
Used with permission. 
Figure 1.19   Telomeres and telomerase 
 
(A) Removal of the RNA primer at the 3' end of the lagging strand leaves a region of DNA at the 
end of the telomere unreplicated. (B) The enzyme telomerase binds to the 3' end and extends the 
lagging strand of DNA. An RNA sequence embedded in telomerase provides a template so that, 
overall, the DNA does not get shorter. (C) Bright fluorescent staining marks the telomeric regions 
on these blue-stained human chromosomes. 
20 
Adapted from van Loon, 2010 
Figure 1.20   The most common oxidative DNA lesions  
 
7,8-dihydro-8-oxoguanine (8-oxo-G);7,8-dihydro-8-oxo-adenine (8-oxo-adenine (8-oxo-A); uracil glycol; 
thymine glycol; 5-hydroxycytosine (5-hydroxy-C); 5-hydoxyuracil (5-hydroxy-U); ethenoadenine 
(etheno-A); 2,6-diamino-4-hydroxy-5-formamidopyrimidine (faPy-G) and 4,6-diamino-5-
formamidopyrimidine (faPy-A). 21 
a)    O2
-  +  Fe3+                        Fe2+  +  O2 
 
b)  Fe2+  +  H2O2                     Fe
3+  +  OH-  +  OH. 
 
c)    O2
-  +  H2O2                                 O2  OH
-  +  OH.    
Figure 1.21 b)  Fenton-type reactions undertaken by the mutant SOD1G93A 
The SOD1G93A mutant is understood to exert its oxidative damage to DNA by the 
conversion of hydrogen peroxide to highly toxic hydroxyl radicals by way of these 
Fenton-type reactions. 
Figure 1.21 a)   Diagram of some key redox reactions involved in oxidative toxicity 
Enzymatic inactivation  of superoxide in performed by superoxide dismutase (SOD) . Two 
superoxide radicals and two protons generate the less toxic hydrogen peroxide and oxygen.  
22 
Figure 1. 22  Proposed models for SOD1-mediated toxicity linked to altered conformation 
and/or aggregation of mutant SOD1 subunits 
 
Wild-type SOD1 exists as a dimer with bound Cu and Zn, while mutants are misfolded, unable to 
dimerize or unable to efficiently bind Zn. a) Mutant SOD1 toxicity may result from aberrant oxidative 
chemistry. Misfolded enzymatic subunits admit access of improper substrates to the catalytic copper 
site of SOD1. b−d) Neuronal toxicity arises from protein aggregation. Diffuse or focal aggregates 
sequester key cellular components3 b). Aggregates place an increased burden on protein chaperones, 
which continually try to fold or refold mutant SOD1, leading to c) a reduction in overall protein-
folding chaperone activity d) Accumulation of mutant SOD1 overwhelms the capacity of the ubiquitin 
proteasome pathway to degrade misfolded SOD molecules, but also other critical substrates. 
 
Cleveland and Liu, Nature Medicine,  2000 
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 WT APTX-/- APTX +/- SOD1 G93A APTX-/- SOD1 G93A 
1 A60/61-8 A60-61-2    
2  DAS58/64-5  DAS58/64-3 DAS58/64-4 
3 SA276/267-7 SA275/269-
4 
SA275/269-
7 
  
 
Table 2.i   Codes of MEFs used for survival, comet and senescence assays 
 
 
 
 WT APTX-/- SOD1 G93A APTX-/- SOD1 G93A 
1 SA47-417 SA50-494 SA46-448 SA46-459 
2 SA47-420 SA50-497  SA46-464 
3 C57BL/6J -1 A19-117 SOD/C6-50L SA50-495 
 
Table 2.ii   Codes of adult mice used for comparison of liver IGF1 levels relative to β-actin 
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 Sequence 
APTX 1 5’ – AGCAAGTGGCCTCACATACACATGC – 3’ 
APTX 2 5’ – CTCCTTGCCTGCTTACACTCCAGC – 3’ 
APTX 3 5’ – TTCTCTCCATGACTGGTCATGGC – 3’ 
SOD 1 Forward 5’ - CTAGGCCACAGAATTGAAAGATCT - 3’ 
SOD 1 Reverse 5’ – GTAGGTGGAAATTCTAGCATCATC - 3’ 
SOD 1G93A Forward 5’ – CATCAGCCCTAATCCATCTGA – 3’ 
SOD 1G93A Reverse 5’ – CGCGACTAACAATCAAAGTGA – 3’ 
 
Table 2.iii   Details of primers used for genotyping biopsies 
 
 
  
Oligonucleotide Sequence 
25mer 5’-GACATACTAACTTGAGCGAAACGGT-3’ 
18mer 5’-TCCGTTGAAGCCTGCTTT-3’ 
14mer 5’-AACTCGCTTTGCCA-3’ 
36mer 5’-TAGGCAACTTCGGACGAAACTGTTGAGCGAAACGGT-3’ 
43mer 5’-CCGTTTCGCTCAAGTTAGTATGTCAAAGCAGGCTTCAACGGAT-
3’ 
Competitor 
oligonucleotide 
5’-TCTGCTAGCATCGATCCATG-3’ 
 
Table 2.iv Sequences of the oligonucleotides used to prepare model SSB substrates 
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Primer Sequence  
β-actin Forward 5’-GACGTTGACATCCGTAAAGA-3’ 
β-actin Reverse 5’-AATCTCCTTCTGCATCCTGT-3’ 
IGF-1 Forward 5’-TGCTTGCTCACCTTCACCA-3’ 
IGF-1 Reverse 5’-CAACACTCATCCACAATGCC-3’ 
 
Table 2.v Sequences of the primers used for Q-PCR 
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Aprataxin facilitates  
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single-strand breaks  
in vitro 
 
 
Figures 
 
 
1 
A) 
Figure 3.1 Overexpression and purification of recombinant His-tagged human APTX  
A) Western blot of 10 and 20 μl supernatant samples of BL21 E.Coli culture transformed 
with the pB352_hAPTX bacterial expression vector, pre- and post-induction with 1 M 
IPTG. His-tagged recombinant APTX runs above the 37 kDa marker at approx. 40 kDa.  
B) Flow-through and peak fraction from IMAC show presence of His-APTX. 
C)  Peak recombinant APTX fraction from IMAC was purified by cation exhange 
chromatography. Concentration was calculated to be 6.4 μM using BSA standards of 
1,2,4,8 μg (Recombinant TDP1 was also prepared but was not used in this study). 
C) 
B) Marker   pre-induction   post-induction    
                 10μl      20μl      10μl        20μl 
Rec. 
APTX 
~ 40kDa 
  Eluate   Flow    Marker    
2 
Figure 3.2 MEF lysate, DNA substrate and recombinant protein activity controls 
A) Diagram of the 18mer oligonucleotide used with 3’ phosphotyrosine (18Y) or 3’ phosphate (18P) end. 
B) Diagram showing the 25mer oligonucleotide used with 5’ adenosine monophosphate (25A) or 
phosphate (25P).  
C) Lysate activity control. In vitro repair assay: 3ug Wt and Aptx-/- lysates both cleaved 3’tyrosine from 
18Y substrate, confirming enzymatic activity in both. The bar chart is a quantification of the products 
of each reaction, showing similar enzyme activity. The signal intensity of the ‘product’ band and the 
‘substrate’ band were quantified as percentages of the total signal intensity, using ImageQuant.  
D) Western blot: aprataxin protein present in Wt, and absent in  Aptx-/- cell lysate, β-actin present in both. 
E) Mutant MEF, recombinant APTX and DNA substrate control: Radiograph showing electrolysed DNA 
substrates alone 1: Mock 25P and 2: Mock 25A, and product of the in vitro repair reactions in with 
25nmol 25A substrate was incubated with  3: Recombinant APTX and 4+5: 0.5 μg and 1.0 μg Wt MEF 
lysate show DNA-adenylate cleavage activity to convert the 25A substrate into the 25P product. 6+7: 
Similar concentrations of Aptx-/- lysate show no evidence of DNA-adeynlate cleavage activity, the 25A 
substrate remains unprocessed, confirming a lack of aprataxin activity. 
1      2     3       4       5       6      7 
3 
18 14 
36 
OH Pol 32P 
 
B) 
18 
Marker 
18 
Wt     Aptx-/- 
Gap filled 
5’ strand 
displaced 
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C) 
Figure 3.3 In vitro DNA single-strand repair assay showing 3’ extension by Wt and Aptx-/- lysate 
A) Diagram to show the gap substrate used in all further in vitro repair assays. An 18mer and 14mer is 
annealed to a 36mer, forming a DNA duplex with a 3 nucleotide gap.  
B) Simplified diagram of the gap substrate showing the 18mer 3’ hydroxyl – a potential substrate for 
gap-filling by a polymerase.  
C) In vitro DNA single strand repair experiments: 25nmoles gap substrate were incubated with 1μg 
MEF cell-free extract, for 30min at 37oC in reaction buffer containing 10 μM deoxynucleoside 
triphosphates (dNTPs), 1 mM ATP, 1000-fold molar excess of competitor oligonucleotide. The 
image is a radiograph showing the products of a gap-filling in vitro experiment, separated by urea 
electrophoresis DNA gel. Radiolabelled DNA products were visualised on a phosphorimager. This 
is a representative radiograph of three repeats. 
A) 
32PTCCGTTGAAGCCTGCTTT AACTCGCTTTGCCA  
TAGGCAACTTCGGACGAAACTGTTGAGCGAAACGGT 
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Figure 3.4: Effect of Wt or Aptx-/- lysate on 3’ extension of a DNA gap substrate in vitro  
A and B: Radiographs of electrolysed products of two similar experiments. 100nm gap substrate was 
incubated with either Wt or Aptx-/- lysate for 30 min at 37oC. C and D are quantifications of A and B 
calculated using ImageQuant. E: Data from C and D combined SD calculated and plotted as error bars. 
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Figure 3.5: Effect of recombinant proteins on 3’ extension of a DNA gap substrate, in the 
presence of either Wt or Aptx-/- lysate in vitro 
A) Radiograph showing eletrolysed products of in vitro repair reactions in which 100nm gap 
substrate were incubated with 1μg MEF lysates, Wt or Aptx-/-, with the addition of recombinant 
PNK (1nM), and/or Pol-β (0.8μM) and/or DNA Ligase III α (10nM). Reactions were run for 1.5 
hrs and stopped with 90% formamide stop buffer. Products were run on a 15% denaturing PAGE 
gel.   
B) Quantification of lanes 3 and 6, which show the gel-separated products of reactions containing 
PNK and Pol-β and either Wt or Aptx-/- lysates, were calculated using ImageQuant software and 
plotted as a bar chart. 
A) 
B) 
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Figure 3.6: Effect of recombinant Pol β and Wt or Aptx-/- lysate on DNA gap substrate in vitro  
A, B and C: Radiographs showing electrolysed products of in vitro repair assays in which 100nm gap 
substrate, incubated with a range of Pol β concentrations, from 12.5nM to 60nM in the presence of 
either Wt or Aptx-/- lysate for 30 min at 37oC. 3’ extension was facilitated in the presence of Wt lysate, 
compared with 3’ extension in the presence of Aptx-/- lysate, over a range of concentrations of Pol-β.  
D, E and F are quantifications of A, B and C, respectively, calculated with ImageQuant. 
Wt + 60nM Polβ 
Aptx-/- + 60nM Polβ 
Wt + 12.5nM Polβ Wt + 30nM Polβ 
Aptx-/- + 30nM Polβ Aptx-/- + 12.5nM Polβ 
Wt  Aptx-/-  Wt  Aptx-/-  
Wt  Aptx-/-   
7 
Figure 3.7: Effect of recombinant Pol-β and Wt or Aptx-/- lysate on DNA gap substrate in vitro  
A: Radiograph showing electrolysed products of in vitro repair assays in which100nm gap substrate were 
incubated with either Wt or Aptx-/- lysate alone or with recombinant Pol β at concentrations ranging from 
62nM to 250nM, for 30 min at 37oC. 3’ extension was facilitated in the presence of Wt lysate, compared 
with 3’ extension in the presence of Aptx-/- lysate, over a range of concentrations of Pol β. 
B, C and D are quantifications of the Pol β titration in A. 
Wt + 250nM Polβ 
Aptx-/- + 250nM Polβ 
Wt + 125nM Polβ 
Aptx-/- + 125nM Polβ 
Wt + 62nM Polβ 
Aptx-/- + 62nM Polβ 
Wt Aptx-/- 
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Figure 3.8: Recombinant aprataxin promotes 3’ extension by recombinant Pol β  
A: Radiograph showing electrolysed products of in vitro repair assays in which 100nm gap 
substrate was incubated with 6 or 12 nM Pol-β in the presence of either 180nM APTX or 180nM 
BSA, for 30 mins at 37oC. Reactions were stopped with formamide stop buffer and products 
were separated on a 15% urea gel. B is a quantification of % signal intensity of each product size 
using ImageQuant and plotted on a bar chart. 
A 
B 
Product size 
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Figure 3.9: Aprataxin and Pol β both interact with XRCC1-LigIII in the major multi-protein 
complex of the SSBR machinery  
 
DNA Ligase IIIα interacts with the NEIL1 and NEIL2 - DNA glycosylases that repair oxidized bases 
in a sub-pathway of BER, which is dependent upon PNK but not APE1. PNK, Aprataxin and APLF 
all have overlapping binding sites on XRCC1. Pol β also interacts with XRCC1, at the NTD. Data 
presented in this chapter suggest that they might interact directly in vitro. Further studies are necessary 
to investigate their interaction in cells. 
Figure 3.10: Diagram showing the interaction of aprataxin with the DSBR machinery 
  
The X family of polymerases include Pol λ and μ terminal deoxynucleotidyl transferase (TdT). TdT 
is expressed only in lymphoid tissue, and adds "n nucleotides" to double-strand breaks formed 
during V(D)J recombination to promote immunological diversity. An interaction between aprataxin 
and Pol β may indicate additional interactions with other polymerases, which would  
suggest a role in other processes. 
10 
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survival,senescence,  
and DNA repair in cells? 
 
Figures 
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Figure 4.1: Aptx-/- MEFs show slightly slower growth but similar sensitivity to X-ray irradiation and 
H2O2 compared with Wt counterparts   
 
A) Western blots of Wt and Aptx-/- MEF lysates confirmed lack of aprataxin expression in MEFs lacking the 
aprataxin gene. 
B) Cells were counted at each passage. Population doublings were plotted against number of days in culture, 
showing that Aptx-/- MEFs grew more slowly in culture than Wt MEFs, from passage 1. The same trend was 
seen in MEFs cultured from a separate litter (Supp. Fig. 1 in Appendix II).  
C) Wt and Aptx-/- MEFs were X-ray irradiated at the doses indicated and colonies were counted four days 
after treatment. The surviving fraction was plotted against X-ray irradiation dose. 
D) Wt and Aptx-/- MEFs were treated with H2O2 at the doses indicated for ten minutes in the dark at RT. 
Colonies were counted four days after treatment. The surviving fraction was plotted against H2O2  dose. 
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Figure 4.2: Aptx-/- MEFs have accelerated senescence phenotype compared to Wt  
 
A) Representative image of β-Galactosidase at pH6 in Wt and Aptx-/- MEFs at passage 10. showed 
an accelerated passage-dependent senescence, relative to wild-type MEFs. Data were analysed by 
the two-way ANOVA statistical test. Significance was calculated to be p < 0.01.  
B) RNA synthesis  recovery was measured by incorporation of tritiated uridine over   15 mins in Wt 
and Aptx-/- MEFs after treatment with 50 μM H2O2 for 10mins, and plotted as a percentage of the 
RNA synthesis measured in untreated cells. MEF DNA was pre-labelled by incubation with 14C-
thymidine for 48 h in order to normalise RNA synthesis to DNA content. 
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Figure 4.3: SOD1G93A expression reveals defective oxidative repair in Aptx-/- MEFs 
     
A) MEF lysates (1: Wild-type 2: Aptx-/- 3: Aptx-/- 4: SOD1G93A 5: Aptx-/-/SOD1G93A show the presence of 
endogenous and mutant SOD1 by western blot. 
Comet assays 
B) All  cell lines show similar damage induction with 20 Gy γ-radiation.  
C) No significant difference in repair rate in Aptx-/- Sod1G93A MEFs relative to SOD1G93A MEFs. 
D) All mutant cell lines used showed similar levels of DNA breaks induced with H2O2. 
E) Aptx-/-SOD1G93A MEFs show synergistic repair defect at the 30 min repair time-point after H2O2  
(p < 0.001). Data were analysed using a two-way ANOVA statistical test. 
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Figure 4.4  SOD1G93A mutation reveals a survival defect in aprataxin-deleted MEFs 
following high doses of X-ray irradiation and moderate doses of H2O2 
 
A) Aptx-/-/SOD1G93A MEFs showed synergistic survival defect at 5 Gy X-ray (p = 0.03). 
B) Aptx-/-/SOD1G93A MEFs show synergistic survival defect at 100 μM (p = 0.015) and  
      200 μM (p = 0.02) H2O2. Statistical test used: Student’s T-test. 
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Figure 5.1  Southern blot comparing telomeric length in chromosomal MEF DNA 
 
Assay was performed using the TeloTAGGG Telomere Length Assay® (Roche) and according to the 
instructions therein. Briefly, DNA was extracted from MEFs, digested by a Hinf I/Rsa I enzyme mixture 
for 2 h at 37oC. DNA was separated by gel electrophoresis and transferred to a positively charged nylon 
membrane by Southern blotting. DNA was fixed by UV-crosslinking at 120 mJ. A digoxigenin-labeled 
probe was used to bind to telomeric sequences. Subsequent incubation with Anti-DIG-AP for 30 min at 
RT, followed by substrate solution containing CDP-Star for 2-5 min at RT Lane produced 
chemiluminescent signal that was detected with X-ray film, indicating the length of telomeric sequences 
present in each sample. M: DNA size marker. Signal relates to telomeric sequences in eletrophoresed 
genomic DNA extracted from P8 MEFs   1: Wt   2: Aptx-/-   3: SOD1G93A   4: SOD1G93A/Aptx-/-  
* The final two sample lanes were disrupted by a pierced well.  
M 
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Figure 5.2  Southern blot reveals no significant difference in telomere stability with aprataxin 
 deletion regardless of SOD1 background, with or without oxidative damage  
  
A) Procedure as before (Figure 5.1) was carried out on genomic DNA extracted from P8 Wt and Aptx-
/- MEFs without (-) or with (+) 50uM H2O2 treatment for 10 mins on three consecutive days. [lane 
1 = Wt (-), lane 2 = Wt (+), lane 3 = Aptx-/- (-), lane 4 = Aptx-/- (+), lane 5 = blank, lane 6 = 
telomeric DNA control].  
B) Procedure as before (Figure 5.1) was carried out on genomic DNA extracted from P8 MEFs 
without (-) or with (+) 50uM H2O2 treatment for 10 mins on three consecutive days [lane 1 = 
SOD1G93A (-), lane 2 = SOD1G93A (+), lane 3 = SOD1G93A/Aptx-/- (-), lane 4 = SOD1G93A/Aptx-/- 
(+), lane 5 = blank, lane 6 = telomeric DNA control]. 
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Figure 5.3. FACS analysis show a modest accumulation in S phase and a greater proportion of 
dead cells in the mutant cell populations compared with wild-type counterparts 
 
FACS profiles of MEFs of each genotype:  Wt,  Aptx-/-, SOD1G93A, Aptx-/-SOD1G93A. Cells were 
sorted according to DNA density and cell size. The percentage of cells within gates 3, 4, 5 – relating 
approximately to cells in the G1, S and G2 phases of the cell cycle respectively, were plotted - as 
well as those cells with DNA density: cell size profiles suggesting that they were dead. The bar 
chart shows the combined data from two experiments using the same cultures, at passage 3 and 4.  
Raw data is provided in Figure 5.4 A and B. 
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Figure 5.4 A  FACS analysis show a modest accumulation in S phase and a greater proportion of 
dead cells in the mutant cell populations compared with wild-type 
 
FACS profiles of MEFs of each genotype: Top left: Wt, top right: Aptx-/-, bottom left: SOD1G93A, bottom 
right: Aptx-/-SOD1G93A. FACS analysis profiles of MEFs of each genotype from separate cultures gave 
similar results (Figure 5.4). P3 = approx. proportion of cells in S phase, P4 = approx. proportion of cells in 
S phase, P5 = approx. proportion of cells in G2 phase.  
Wt Aptx-/- 
SOD1G93AAptx-/- SOD1G93A 
A 
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Figure 5.4. B  FACS analysis show a modest accumulation in S phase and a greater proportion of 
dead cells in the mutant cell populations compared with wild-type  
 
FACS analysis profiles of MEFs of each genotype: Top left, Wt, top right Aptx-/-, bottom left SOD1G93A, 
bottom right SOD1G93A. P3 = approx. proportion of cells in S phase, P4 = approx. proportion of cells in S 
phase, P5 = approx. proportion of cells in G2 phase.  
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Figure 5.5  IGF-1 expression is down-regulated in SOD1G93AAptx-/- mouse liver 
 
A) RNA was extracted using an RNeasy Plus Mini Kit (Qiagen) in triplicate from at least two livers from 
each genotype. cDNA was generated with the Promega reverse transcription system. SYBR Green master 
mix and a Stratagene Mx4000 qPCR system was used for analysis. qPCR analysis revealed no significant 
difference between wild-type and either of the single mutants - aprataxin-deleted or SOD1G93A, but a 
marked down-regulation of IGF-1 was revealed in SOD1G93AAptx-/- double mutants relative to wild-type 
(p < 0.01) and SOD1G93A mutants (p < 0.001). Data was analysed across experiments by Student’s T-Test.  
 
B)  cDNA generated as above was amplified by PCR using Taq DNA polymerase (Roche) with either  
β-actin primers (reactions 1-4) or IGF-1 primers (reactions 5-8). Separate reactions were stopped at 
24,27,30 and 33 cycles and run on a 0.8% agar gel.  
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Figure 6.1   Model for AOA1 as a cerebellar-specific progeroid disorder  
A schematic model of AOA1 disease progression, in which symptoms arise as the results of 
reiterative cycles of DNA damage and response – leading to increasing loss of function and 
eventual cell death. 
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